UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 31, 2018

OR

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________ to ______________

Commission file number 001-35592

COUNTERPATH CORPORATION
(Exact name of registrant as specified in its charter)

Nevada 20-0004161
(State or other jurisdiction of incorporation or (IRS Employer Identification No.)
organization)  

Suite 300, One Bentall Centre, 505 Burrard Street, Vancouver, British Columbia, Canada V7X 1M3
(Address, including zip code, of principal executive offices)

(604) 320-3344
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X] No [   ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes [X] No [   ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [   ] Accelerated filer [   ]
Non-accelerated filer [   ] Smaller reporting company [X]
    Emerging growth company [   ]

1


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [   ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [   ]  No [X]

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 5,945,115 shares of common stock issued and outstanding as of December 7, 2018.

2


COUNTERPATH CORPORATION
OCTOBER 31, 2018 QUARTERLY REPORT ON FORM 10-Q

INDEX

    Page
     
  PART I – FINANCIAL INFORMATION  
     
Item 1. Financial Statements. 4
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 24
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk. 35
     
Item 4. Controls and Procedures. 35
     
  PART II – OTHER INFORMATION  
     
Item 1. Legal Proceedings. 36
     
Item 1A. Risk Factors. 36
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 44
     
Item 3. Defaults Upon Senior Securities. 45
     
Item 4. Mine Safety Disclosures. 45
     
Item 5. Other Information. 45
     
Item 6. Exhibits. 45

3


PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.

It is the opinion of management that the interim consolidated financial statements for the quarter ended October 31, 2018 include all adjustments necessary in order to ensure that the interim consolidated financial statements are not misleading.

In the interim consolidated financial statements for the quarter ended October 31, 2018, all amounts are expressed in United States dollars, unless otherwise indicated. The interim consolidated financial statements for the quarter ended October 31, 2018 are prepared in accordance with generally accepted accounting principles in the United States of America.

COUNTERPATH CORPORATION
INDEX TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)
(Stated in U.S. Dollars)

  Page
   
Interim Consolidated Balance Sheets 5
   
Interim Consolidated Statements of Operations 6
   
Interim Consolidated Statements of Comprehensive Loss 6
   
Interim Consolidated Statements of Cash Flows 7
   
Interim Consolidated Statement of Changes in Stockholders’ Equity 8
   
Notes to the Interim Consolidated Financial Statements 9

4


COUNTERPATH CORPORATION
INTERIM CONSOLIDATED BALANCE SHEETS
(Stated in U.S. Dollars)
(Unaudited)

    October 31,     April 30,  
    2018     2018  
             
Assets            
 Current assets:            
     Cash $  1,848,630   $  2,348,883  
     Accounts receivable (net of allowance for doubtful accounts of $1,071,383 (2018 - $322,638))   2,241,779     3,509,010  
   Deferred sales commission costs – current – Note 4   103,292      
   Derivative assets   3,457      
   Prepaid expenses and deposits   177,585     191,245  
       Total current assets   4,374,743     6,049,138  
             
   Deposits   96,706     98,633  
   Deferred sales commission costs – non-current – Note 4   62,253      
   Equipment   94,631     121,819  
   Goodwill   6,690,425     6,843,575  
   Intangibles and other assets   220,638     221,062  
Total Assets $  11,539,396   $  13,334,227  
             
Liabilities and Stockholders’ Equity            
 Current liabilities:            
   Accounts payable and accrued liabilities $  2,514,742   $  2,437,733  
   Derivative liability   13,719      
   Unearned revenue   2,597,465     2,565,876  
   Customer deposits   3,137     2,200  
   Accrued warranty   56,208     63,130  
Total current liabilities   5,185,271     5,068,939  
             
   Deferred lease inducements   9,071     14,339  
   Loan payable – Note 7   1,000,000      
   Unrecognized tax liability   9,763     9,763  
       Total liabilities   6,204,105     5,093,041  
             
 Stockholders’ equity:            
 Preferred stock, $0.001 par value
   Authorized: 100,000,000
   Issued and outstanding: October 31, 2018 – nil; April 30, 2018 – nil
       
 Common stock, $0.001 par value – Note 8
   Authorized: 100,000,000
   Issued:
   October 31, 2018 – 5,943,082; April 30, 2018 – 5,930,468
  5,943     5,931  
 Additional paid-in capital   75,520,205     75,170,181  
 Accumulated deficit – Note 4   (66,642,356 )   (63,701,685 )
 Accumulated other comprehensive loss – currency translation adjustment   (3,548,501 )   (3,233,241 )
     Total stockholders’ equity   5,335,291     8,241,186  
Liabilities and Stockholders’ Equity $  11,539,396   $  13,334,227  
             
Commitments – Note 11            
Contingencies – Note 12            
Going concern – Note 2            

See accompanying notes to the interim consolidated financial statements
5


COUNTERPATH CORPORATION
INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS
(Stated in U.S. Dollars)
(Unaudited)

    Three Months Ended     Six Months Ended  
    October 31,     October 31,  
    2018     2017     2018     2017  
Revenue – Note 10:                        
   Software $  923,416   $  1,816,867   $  2,279,418   $  3,515,760  
   Subscription, support and maintenance   1,319,840     981,619     2,570,860     1,948,681  
   Professional services and other   198,005     612,079     478,813     1,058,930  
             Total revenue   2,441,261     3,410,565     5,329,091     6,523,371  
Operating expenses:                        
   Cost of sales (includes depreciation of $528 (2017 – $3,168))   623,811     380,822     1,219,367     769,065  
   Sales and marketing   967,689     1,031,227     1,962,649     2,035,511  
   Research and development   1,391,737     1,329,437     2,794,693     2,690,910  
   General and administrative   1,550,101     714,598     2,541,739     1,607,185  
             Total operating expenses   4,533,338     3,456,084     8,518,448     7,102,671  
Loss from operations   (2,092,077 )   (45,519 )   (3,189,357 )   (579,300 )
Interest and other income (expense), net:                        
   Interest and other income                        
   Interest expense   (4,661 )   (162 )   (4,666 )   (215 )
   Foreign exchange gain (loss)   43,535     204,515     124,471     (414,184 )
   Change in fair value of derivative instruments   (10,554 )       (5,152 )    
             Total interest and other income (expense), net   28,320     204,353     114,653     (414,399 )
Net income (loss) for the period $  (2,063,757 ) $  158,834   $  (3,074,704 ) $  (993,699 )
                         
Net income (loss) per share – Note 13:                        
   Basic $  (0.35 ) $  0.03   $  (0.52 ) $  (0.19 )
   Diluted $  (0.35 ) $  0.03   $  (0.52 ) $  (0.19 )
                         
Weighted average common shares outstanding:                        
   Basic   5,941,812     5,487,765     5,937,115     5,262,359  
   Diluted   5,941,812     5,892,580     5,937,115     5,262,359  

See accompanying notes to the interim consolidated financial statements

COUNTERPATH CORPORATION
INTERIM CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(Stated in U.S. Dollars)
(Unaudited)

    Three Months Ended     Six Months Ended  
    October 31,     October 31,  
    2018     2017     2018     2017  
Net income (loss) for the period $  (2,063,757 ) $  158,834   $  (3,074,704 ) $  (993,699 )
Other comprehensive loss:                        
   Foreign currency translation adjustments   (112,295 )   (425,942 )   (315,260 )   770,611  
Comprehensive loss $  (2,176,052 ) $  (267,108 ) $  (3,389,964 ) $  (223,088 )

See accompanying notes to the interim consolidated financial statements

6


COUNTERPATH CORPORATION
INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
(Stated in U.S. Dollars)
(Unaudited)

    Six Months Ended  
    October 31,  
    2018     2017  
             
Cash flows from operating activities:            
 Net loss for the period $  (3,074,704 ) $  (993,699 )
 Adjustments to reconcile net loss to net cash used in operating activities:            
     Deferred lease inducements   (4,947 )   (5,057 )
     Depreciation and amortization   47,309     55,869  
     Unrealized foreign exchange (gain) loss   (171,975 )   383,154  
     Stock-based compensation – Note 8   339,597     406,959  
     Issuance of common stock for services       2,776  
     Change in fair value of derivative instruments   10,262      
             
 Changes in assets and liabilities:            
     Accounts payable and accrued liabilities   98,933     38,392  
     Accounts receivable   1,267,223     (1,685,153 )
     Deferred sales commission costs – Note 4   (31,512 )    
     Accrued warranty   (6,922 )   6,295  
     Customer deposits   937     (3,831 )
     Prepaid expenses and deposits   12,887     29,060  
     Unearned revenue – Note 4   31,589     237,611  
Net cash used in operating activities   (1,481,323 )   (1,527,624 )
             
Cash flows from investing activities:            
 Purchases of equipment   (17,969 )   (51,818 )
 Purchases of intangibles   (3,314 )   (10,585 )
Net cash used in investing activities   (21,283 )   (62,403 )
             
Cash flows from financing activities:            
 Net proceeds from issuance of common stock   10,439     1,195,776  
 Repurchases of common stock       (33,220 )
 Proceeds received from loan payable – Note 7   1,000,000      
Net cash provided by financing activities   1,010,439     1,162,556  
             
Foreign exchange effect on cash   (8,086 )   38,584  
             
Decrease in cash   (500,253 )   (388,887 )
             
Cash, beginning of the period   2,348,883     2,071,019  
Cash, end of the period $  1,848,630   $  1,682,132  
             
Supplemental disclosure of cash flow information            
 Cash paid for:            
     Interest $  –   $  162  
     Taxes $  –   $  –  
             
 Non cash transactions – Note 8            

See accompanying notes to the interim consolidated financial statements

7


COUNTERPATH CORPORATION
INTERIM CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY
for the Six Months Ended October 31, 2018
(Stated in U.S. Dollars)
(Unaudited)

    Common Shares     Treasury Shares                          
                                        Accumulated        
    Number           Number           Additional           Other        
    of           of           Paid-in     Accumulated     Comprehensive        
    Shares     Par Value     Shares     Par Value     Capital     Deficit     Loss     Total  
                                                 
Balance, April 30, 2017   5,005,245   $  5,005     (59,900 ) $  (60 ) $  71,680,575   $  (60,481,015 ) $ (4,025,196 ) $  7,179,309  
                                                 
Shares issued – Note 8:                                                
Private placement, net of share issuance costs   539,240     540             1,165,956             1,166,496  
Issuance of common stock for services   14,000     14                 33,303                 33,317  
Share repurchase plan           (13,600 )   (14 )   (33,630 )           (33,644 )
Cancellation of shares   (71,500 )   (72 )   71,500     72     425             425  
Stock-based compensation                   406,959             406,959  
Employee share purchase program   12,165     12             29,268             29,280  
Net loss for the period                       (993,699 )       (993,699 )
Foreign currency translation adjustment                           770,611     770,611  
Balance, October 31, 2017   5,499,150   $  5,499     (2,000 ) $  (2 ) $  73,282,856   $  (61,474,714 ) $ (3,254,585 ) $  8,559,054  
                                                 
                                                 
Balance, April 30, 2018   5,930,468   $  5,931       $  –   $  75,170,181   $  (63,701,685 ) $ (3,233,241 ) $  8,241,186  
Adoption of ASC 606 – Note 4                       134,033         134,033  
Balance, May 1, 2018   5,930,468   $  5,931       $  –   $  75,170,181   $  (63,567,652 ) $ (3,233,241 ) $  8,375,219  
                                                 
Shares issued – Note 8:                                                
Stock-based compensation                   339,597             339,597  
Employee share purchase program   5,656     5             12,813             12,818  
Exercise of stock options   6,958     7             (2,386 )           (2,379 )
Net loss for the period                       (3,074,704 )       (3,074,704 )
Foreign currency translation adjustment                           (315,260 )   (315,260 )
Balance, October 31, 2018   5,943,082   $  5,943       $  –   $  75,520,205   $  (66,642,356 ) $ (3,548,501 ) $  5,335,291  

See accompanying notes to the interim consolidated financial statements

8


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)

Note 1 Nature of Operations
   

CounterPath Corporation (the “Company”) was incorporated in the State of Nevada on April 18, 2003. The Company focuses on the design, development, marketing and sales of software applications and related services, such as pre and post sales technical support and customization services, that enable enterprises and telecommunication service providers to deliver Unified Communications (“UC”) services, including voice, video, messaging and collaboration functionality, over their Internet Protocol, or IP, based networks. The Company’s products are sold either directly or through channel partners, to small, medium and large businesses (“enterprises”) and telecom service providers, in North America, and in Europe, Middle East, Africa (collectively “EMEA”), Asia Pacific and Latin America.

   
Note 2

Basis of Presentation and Principles of Consolidation

   

The accompanying interim consolidated financial statements have been prepared in accordance with the accounting principles generally accepted in the United States of America (“U.S. GAAP”) and are stated in U.S. dollars, except where otherwise disclosed.

   

These interim consolidated financial statements include the accounts of the Company and its wholly- owned subsidiaries, CounterPath Technologies Inc., a company existing under the laws of the province of British Columbia, Canada, BridgePort Networks, Inc. (“BridgePort”), a company incorporated under the laws of the state of Delaware and CounterPath LLC, a company formed on August 27, 2018, under the laws of the state of Delaware. The results of NewHeights Software Corporation (“NewHeights”), which subsequently was amalgamated with another subsidiary to become CounterPath Technologies Inc., are included from August 2, 2007, the date of acquisition. The results of FirstHand Technologies Inc. (“FirstHand”), which subsequently was amalgamated with CounterPath Technologies Inc., and BridgePort are included from February 1, 2008, the date of acquisition. All inter-company transactions and balances have been eliminated.

   

These interim consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities and commitments in the normal course of business.

   
 

Going Concern

   

The Company has experienced recurring losses and has an accumulated deficit of $66,642,356 as of October 31, 2018, as a result of flat to declining revenues resulting from a number of factors including its buildout of a cloud based subscription platform concurrent with the change of its licensing model to subscription based licensing and has not reached profitable operations which raises substantial doubt about its ability to continue operating as a going concern within one year of the date of issuance of the financial statements.

   

To alleviate this situation, the Company has plans in place to improve its financial position and liquidity, while executing on its growth strategy, by managing and or reducing costs that is not expected to have an adverse impact on the ability to generate cash flows, as the transition to its software as a service platform and subscription licensing continues.

   

The Company has historically been able to manage liquidity requirements through cost management and cost reduction measures, supplemented with raising additional financing. During the quarter ended October 31, 2018, the Company entered into a loan agreement for an aggregate principal amount of up to $3,000,000. See Note 7 – Loan Payable for further detail. As of October 31, 2018, the Company has no other commitments to raise funds.

9


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)

 

Interim Reporting

   

The information presented in the accompanying interim consolidated financial statements is without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading.

   

These statements reflect all adjustments, which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in accordance with generally accepted accounting principles in the United States of America. Except where noted, these interim financial statements follow the same accounting policies and methods of their application as the Company’s April 30, 2018 annual audited consolidated financial statements. All adjustments are of a normal recurring nature. It is suggested that these interim financial statements be read in conjunction with the Company’s April 30, 2018 annual audited consolidated financial statements.

   

Operating results for the three and six months ended October 31, 2018 are not necessarily indicative of the results that can be expected for the year ending April 30, 2019.

   
Note 3

Summary of Significant Accounting Policies

   

The significant accounting policies used in preparation of these interim consolidated financial statements are disclosed in our Annual Report on Form 10-K for the fiscal year ended April 30, 2018 filed with the Securities Exchange Commission on July 25, 2018, and there have been no changes to the Company's significant accounting policies during the three and six months ended October 31, 2018, except for the revenue recognition policy, described in Note 4 – Revenue Recognition under ASC 606 , that was updated as a result of adopting Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers: Topic 606 (ASU 2014-09 or ASC 606). ASU 2014-09 also included Subtopic 340-40, Other Assets and Deferred Costs - Contracts with Customers . All amounts and disclosures set forth herein are in compliance with these standards.

   
 

Concentrations of Credit Risk

   

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and accounts receivable. The Company has exposure to credit risk to the extent cash balances exceed amounts covered by federal deposit insurance; however, the Company believes that its credit risk on cash balances is immaterial. The Company is also subject to concentrations of credit risk in its accounts receivable. The Company monitors and actively manages its receivables, and from time to time will insure certain receivables with higher credit risk and may require collateral or other securities to support its accounts receivable.

   

Revenue from significant customers for the three and six months ended October 31, 2018 and 2017 is summarized below:


                                                                                                      Three Months Ended     Six Months Ended  
      October 31,     October 31,  
    2018        2017     2018     2017  
  Customer A   14%     10%     8%     6%  

10


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)

The table below presents significant customers who accounted for greater than 10% of total accounts receivable as of October 31, 2018 and April 30, 2018:

      October 31,     April 30,  
      2018     2018  
  Customer B   10%     2%  
  Customer C   10%     6%  
  Customer D   2%     13%  
  Customer E   –%     18%  

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are presented net of an allowance for doubtful accounts.

      October 31,     April 30,  
      2018     2018  
  Balance of allowance for doubtful accounts, beginning of period $  322,638   $  80,232  
  Bad debt provision   748,745     578,024  
  Write-off of receivables       (335,618 )
  Balance of allowance for doubtful accounts, end of period $  1,071,383   $  322,638  

The Company determines the allowance for doubtful accounts by considering a number of factors, including the length of time the accounts receivable are beyond the contractual payment terms, previous loss history, and the customer’s current ability to pay its obligation. When the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, the Company records a charge to the allowance to reduce the customer’s related accounts.

Derivative Instruments

The Company accounts for derivative instruments, consisting of foreign currency forward contracts, pursuant to the provisions of ASC 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires the Company to measure derivative instruments at fair value and record them in the balance sheet as either an asset or liability and expands financial reporting about derivative instruments and hedging activities by requiring enhanced disclosures to enable investors to better understand their effects on an entity’s financial position, results of operations and cash flows. The Company does not use derivative instruments for trading purposes. ASC 815 also requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.

The Company also routinely enters into foreign currency forward contracts, not designated as hedging instruments, to protect the Company from fluctuations in exchange rates. Gains or losses arising out of marked to market fair value valuation of non-designated forward contracts are recognized in net income.

The Company records foreign currency option and forward contracts on its Consolidated Balance Sheets as derivative assets or liabilities depending on whether the fair value of such contracts is a net asset or net liability, respectively. See Note 5 - Derivative Instruments for further detail. The Company did not enter any foreign currency derivatives designated as cash flow hedges in the three and six months ended October 31, 2018.

11


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)

  Recently Adopted Accounting Pronouncements
   

In May 2014, FASB issued ASU 2014-09, Revenue From Contracts With Customers (“Topic 606”) which supersedes the revenue recognition requirements in Topic 605 “Revenue Recognition” (“Topic 605”) and requires entities to recognize revenue when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods and services. The Company adopted ASU 2014-09 as of May 1, 2018 using the modified retrospective transition method. See Note 4 – Revenue Recognition under ASC 606 for further details.

   
 

Recently Issued Accounting Pronouncements

   

In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities, which amends the presentation and disclosure requirements and changes how companies assess effectiveness. The amendments are intended to more closely align hedge accounting with companies’ risk management strategies, simplify the application of hedge accounting, and increase transparency as to the scope and results of hedging programs. This amendment is effective for annual periods beginning after December 15, 2018, including interim periods within those periods. Early application is permitted. The Company is currently assessing the future impact of this update on its consolidated financial statements and related disclosures.

   

In January 2017, the FASB issued ASU 2017-04, Intangibles – Goodwill and Other: Simplifying the Test for Goodwill Impairment, which amends the guidance to eliminate Step 2 from the goodwill impairment test. Instead, under the amendments in the new guidance, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The amendments will be effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. The Company is evaluating the impact of this amendment on its consolidated financial statements and related disclosures.

   

In June 2016, the FASB issued ASU 2016-13, Financial Instruments: Measurement of Credit Losses on Financial Instruments which amends the guidance on measuring credit losses on financial assets held at amortized cost. The amendment is intended to address the issue that the previous “incurred loss” methodology was restrictive for a company’s ability to record credit losses based on not yet meeting the “probable” threshold. The new language will require these assets to be valued at amortized cost presented at the net amount expected to be collected will a valuation provision. The amendments will be effective for fiscal years beginning after December 15, 2019. The Company is evaluating the impact of this amendment on our consolidated financial statements and related disclosures.

   

In February 2016, FASB issued ASU 2016-02, Leases . The guidance would require lessees to recognize most leases on their balance sheets as lease liabilities with corresponding right -of-use assets. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2018. The Company is currently evaluating the impact of its pending adoption of ASU 2016-02 on its consolidated financial statements.

   
Note 4

Revenue Recognition under ASC 606

   

On May 1, 2018, the Company adopted the new accounting standard, ASC 606 “Revenue from Contracts with Customers” and all related amendments to the new accounting standard to contracts using the modified retrospective method. The Company recognized the cumulative effect of initially applying the new revenue recognition standard to contracts with open performance obligations as of May 1, 2018, as an adjustment to the opening balance of retained earnings. Results of the reporting period beginning May 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with the Company's historic accounting under ASC 605.

12


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)

Revenues from contracts with customers are recognized when control of promised goods and services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services.

The Company recognizes revenue using the five-step model as prescribed by ASC 606:

  1)

Identification of the contract, or contracts, with a customer;

  2)

Identification of the performance obligations in the contract;

  3)

Determination of the transaction price;

  4)

Allocation of the transaction price to the performance obligations in the contract; and

  5)

Recognition of revenue when or as, the Company satisfies a performance obligation.

When a contract with a customer is signed, the Company assesses whether collection of the fees under the arrangement is probable. The Company estimates the amount to reserve for uncollectible amounts at the end of each reporting period based on the aging of the contract balance, current and historical customer trends, and communications with its customers. These reserves are recorded against the related accounts receivable.

The transaction price is the consideration that the Company expects to receive from its customers in exchange for its products or services. In determining the allocation of the transaction price, the Company identifies performance obligations in contracts with customers, which may include products, subscriptions to software and services, support, professional services and training. The Company allocates the transaction price to each performance obligation on a relative standalone selling price basis. The standalone selling price (SSP) is the price at which the Company would sell a promised product or service separately to a customer. The Company determines the SSP using information that may include market conditions or other observable inputs. In certain cases, the Company is able to establish a SSP based on observable prices for products or services sold separately. In these instances, the Company would use a single amount to estimate a SSP. If a SSP is not directly observable, for example when pricing is variable, the Company will use a range of SSP.

In certain circumstances, the Company may estimate SSP for a product or service by applying the residual approach. This approach has been most commonly used when certain perpetual software licenses are only sold bundled with one year of post-contract support or other services, and a price has not been established for the software.

Significant judgement is used to determine SSP and to determine whether there is a variance that needs to be allocated based on the relative SSP of the various products and services. Estimating SSP is a formal process that includes review and approval by the Company’s management.

Software Revenue

The Company generates software revenue primarily on a single fee per perpetual software license basis. The Company recognizes software revenue for perpetual licenses when control has transferred to the customer, which is generally at the time of delivery when the customer has the ability to deploy the licenses, provided all revenue recognition criteria have been met. If the revenue recognition criteria has not been met, the revenue is deferred or not recognized.

Subscription, support and maintenance

Revenue from the Company’s recurring subscription revenue from subscriptions related to our software as a service offering is recognized ratably over the contractual subscription term as control of the goods or services is transferred to the customer, beginning on the date that the subscription is made available to the customer. Support and maintenance revenue is generated from recurring annual software support and maintenance contracts for our perpetual software licenses and is recognized ratably over the term of the service period, which is generally twelve months. Support and maintenance services include e-mail and telephone support, unspecified rights to bug fixes and product updates and upgrades and enhancements available on a when-and-if available basis. Both subscription revenue and support and maintenance revenue are typically billed annually in advance based on the terms of the arrangement.

13


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)

Professional services and other

Professional services and other revenue is generated through services including product configuration and customization, implementation, dedicated engineering and training. The amount of product configuration and customization required by a customer typically increases as the order size increases from a given customer. Services and pricing may vary depending upon a customer’s requirements for customization, implementation and training. Depending on the services to be provided, revenue from professional services and other is generally recognized at the time of delivery when the services have been completed and control has been transferred.

For contracts with elements related to customized network solutions and certain network build-outs or software systems that require significant modification or customization, the Company will recognize revenue using the percentage-of-completion method. In using the percentage-of-completion method, revenues are generally recorded based on completion of milestones as described in the agreement. Profit estimates on long-term contracts are revised periodically based on changes in circumstances and any losses on contracts are recognized in the period that such losses become known.

Unearned Revenue

Unearned revenue represent billings or payments received in advance of revenue recognition and is recognized upon transfer of control. Balances consist primarily of annual support and subscription services and professional services not yet provided as of the balance sheet date.

During the three and six months ended October 31, 2018, the Company recognized $708,052 and $1,655,852 in revenue, respectively, in its consolidated statements of operations that was previously recognized as unearned revenue in the consolidated balance sheets at May 1, 2018.

Costs to Obtain a Customer Contract

Sales commissions and related expenses are considered incremental and recoverable costs of acquiring customer contracts. These costs are capitalized and amortized on a systematic basis, consistent with the timing of revenue recognition over the anticipated benefit period of up to 3.5 years, depending on the products and services. The anticipated benefit period was estimated based on the average length of applicable customer contracts and includes the contract term and any anticipated renewal periods. This amortization expense is recorded in sales and marketing expense within the Company's consolidated statement of operations. The Company has elected to apply a practical expedient that permits the Company to expense costs to obtain a contract as incurred, if the anticipated benefit period is one year or less. From time to time, management will revisit the estimates used in recognizing the costs to obtain customer contracts.

During the three and six months ended October 31, 2018, the Company capitalized approximately $277,332 and $319,132, respectively, of costs to obtain revenue contracts and amortized approximately $59,595 and $113,695 of commissions during those same periods to sales and marketing expense. Capitalized costs to obtain a revenue contract on the Company's condensed consolidated balance sheets totaled approximately $165,545 at October 31, 2018.

14


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)

Costs to Fulfill a Customer Contract

Certain contract costs incurred to fulfill obligations under a contract are capitalized when such costs generate or enhance resources to be used in satisfying future performance obligations and the costs are deemed recoverable. Judgement is used in determining whether certain contract costs can be capitalized. These costs are capitalized and amortized on a systematic basis to match the timing of revenue recognition over the anticipated benefit period of up to 3.5 years, depending on the products and services. The anticipated benefit period was estimated based on the average length of applicable customer contracts and includes the contract term and any anticipated renewal periods. This amortization expense is recorded in cost of sales in the Company’s consolidated statement of operations. From time to time, management will review the capitalized costs for impairment and will also revisit the estimates used in recognizing the costs to fulfill customer contracts.

Adoption Impact of ASC 606

The Company recognized the cumulative effect of initially applying ASC 606 as an adjustment to retained earnings in the condensed consolidated balance sheet as of May 1, 2018:

      Balance at     ASC 606     Balance at  
      April 30, 2018     Adjustments     May 1, 2018  
  Current assets:                  
       Deferred sales commissions costs $  –   $  70,248   $  70,248  
  Non-current assets:                  
       Deferred sales commissions costs $  –   $  63,785   $  63,785  
  Stockholders’ equity:                  
       Accumulated deficit $  (63,701,685 ) $  134,033   $  (63,567,652 )

The following tables summarize the adoption impact of ASC 606 on the Company's condensed consolidated financial statements for the three and six months ended October 31, 2018.

Selected Condensed Consolidated Income Statement Line Items:

      Three Months Ended October 31, 2018  
            ASC 606     (As Reported)  
      ASC 605     Adjustments     ASC 606  
  Revenue:                  
     Software $  935,217   $  (11,801 ) $  923,416  
     Subscription, support and maintenance   1,321,250     (1,410 )   1,319,840  
     Professional services and other   183,564     14,441     198,005  
         Total revenue $  2,440,031   $  1,230   $  2,441,261  
                     
  Operating expenses:                  
     Sales and marketing $  973,263   $  (5,574 ) $  967,689  
  Loss from operations $  (2,098,881 ) $ 6,804   $  (2,092,077 )
                     
  Net loss per share:                  
     Basic and diluted $  (0.35 ) $  –   $  (0.35 )

15


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)

      Six Months Ended October 31, 2018  
            ASC 606     (As Reported)  
      ASC 605     Adjustments     ASC 606  
  Revenue:                  
     Software $  2,311,460   $  (32,042 ) $  2,279,418  
     Subscription, support and maintenance   2,572,447     (1,587 )   2,570,860  
     Professional services and other   438,492     40,321     478,813  
         Total revenue $  5,322,399   $  6,692   $  5,329,091  
                     
  Operating expenses:                  
     Sales and marketing $  1,992,205   $  (29,556 ) $  1,962,649  
  Loss from operations $  (3,225,605 ) $ 36,248   $  (3,189,357 )
                     
  Net loss per share:                  
     Basic and diluted $  (0.52 ) $  –   $  (0.52 )

Selected Condensed Consolidated Balance Line Items:

            October 31, 2018        
            ASC 606     (As Reported)  
      ASC 605     Adjustments     ASC 606  
  Current assets:                  
     Deferred sales commissions costs $  –   $  103,292   $  103,292  
  Current liabilities:                  
     Unearned revenue $  2,604,157   $  (6,692 ) $  2,597,465  
  Non-current assets:                  
     Deferred sales commissions costs $  –   $  62,253   $  62,253  
  Stockholders’ equity:                  
     Accumulated deficit $  (66,801,209 ) $  158,853   $  (66,642,356 )

Selected Condensed Consolidated Statement of Cash Flows Line Items:

      Six Months Ended October 31, 2018  
      ASC 606 (As Reported)  
      ASC 605 Adjustments ASC 606  
  Net loss $  (3,110,952 ) $  36,248   $  (3,074,704 )
  Deferred sales commissions costs $  –   $  (31,512 ) $  (31,512 )
  Unearned revenue $  38,281   $  (6,692 ) $  31,589  
  Unrealized foreign exchange (gain) loss $  (173,931 ) $  1,956   $  (171,975 )
  Net cash provided by operating activities $  (1,481,323 ) $  –   $  (1,481,323 )

Disaggregation of Revenue

The Company disaggregates its revenue by geographic region. See Note 10 – Segmented Information for more information.

16


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)


Note 5 Derivative Instruments
   

In the normal course of business, the Company is exposed to fluctuations in the exchange rates associated with foreign currencies. The Company’s primary objective for holding derivative financial instruments is to manage foreign currency exchange rate risk.

   
 

Foreign Currency Exchange Rate Risk

   

A majority of the Company’s revenue activities are transacted in U.S. dollars. However, the Company is exposed to foreign currency exchange rate risk, inherent in conducting business globally in multiple currencies, primarily from its business operations in Canada.

   

The Company’s foreign currency risk management program includes entering into foreign currency derivatives at various times to mitigate the currency exchange rate risk on Canadian dollar denominated cash flows. These foreign currency forward and option contracts are considered non-designated derivative instruments and are not used for trading or speculative purposes. The changes in fair value and settlements are recorded in change in fair value of derivative instruments, net in the consolidated statement of operations.

   

During the three and six months ended October 31, 2018 and 2017, the Company did not enter into any designated cash flow hedge contracts.

   

The following table summarizes the notional amounts of the Company’s outstanding derivative instruments:


        October 31,     April 30,  
  Fair value of Undesignated Derivatives     2018     2018  
  Foreign currency option contracts   $  2,000,000   $         –  
  Foreign currency forward contracts   $  500,000   $               –  
      $  2,500,000   $            –  

The following table presents the fair values of the Company’s derivative instruments on a gross basis as reflected on the Company’s consolidated balance sheets. The Company did not have any outstanding derivative contracts as of April 30, 2018.

        October 31, 2018  
        Derivative     Derivative  
  Fair value of Undesignated Derivatives     Assets     Liabilities  
  Foreign currency option contracts   $  3,457   $ 13,073  
  Foreign currency forward contracts   $  –   $  646  
      $  3,457   $ 13,719  

During the three and six months ended October 31, 2018, the Company recorded losses of $10,554 and $5,152 in change in fair value of derivative instruments. No such losses were recorded in the prior year as the Company did not enter into any forward and option contracts.
   
Note 6 Fair Value Measurements
   

Assets and liabilities recorded at fair value in the consolidated financial statements are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels directly related to the amount of subjectivity associated with the inputs to valuation of these assets or liabilities are set forth below. Transfers between levels are recognized at the end of each quarter. The Company did not recognize any transfers between levels during the periods presented.

   
  Level 1—Inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities.

17


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)

Level 2—Inputs (other than quoted prices included in Level 1) are observable for the asset or liability, either directly or indirectly such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals.

Level 3— unobservable inputs for the asset or liability which are typically based on an entity’s own assumptions, as there is little, if any, related market activity.

Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.

The carrying values of financial instruments classified as current assets and current liabilities approximates their fair values, based on the nature and short maturity of these instruments, and are presented in the Company’s financial statements at carrying cost.

Financial Instruments Measured at Fair value

The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis as of October 31, 2018 and April 30, 2018.

        Carrying           Fair Value        
  As at October 31, 2018     Amount     Fair Value     Levels     Reference  
  Assets                          
  Cash   $  1,848,630   $  1,848,630     1     N/A  
  Foreign currency option contracts     3,457     3,457     2     Note 5  
      $  1,852,087   $  1,852,087              
                             
  Liabilities                          
  Foreign currency forward and                          
  option contracts   $  13,719   $  13,719     2     Note 5  

        Carrying           Fair Value        
  As at April 30, 2018     Amount     Fair Value     Levels     Reference  
  Cash   $  2,348,883   $  2,348,883     1     N/A  

Financial Instruments Not Measured at Fair Value

The following table presents the Company’s liability that is not measured at fair value as of October 31, 2018, but for which fair value is available:

        Carrying           Fair Value        
  As at October 31, 2018     Amount     Fair Value     Levels     Reference  
  Loan payable   $  1,000,000   $  1,063,688     2     Note 7  

Loan payable is presented on the consolidated balance sheets at carrying cost. The fair value of the fixed interest rate loan is estimated based on observable market prices or inputs. Where observable prices or inputs are not available, valuation models are applied using the net present value of cash flow streams over the term, using estimated market rates for similar instruments and remaining terms.

   
Note 7

Loan Payable

   

On October 10, 2018, the Company entered into a loan agreement (the “Loan Agreement”) with Wesley Clover International Corporation and KMB Trac Two Holdings Ltd for an aggregate principal amount of up to $3,000,000. Pursuant to the terms of the Loan Agreement, the loan is unsecured and will be made available in multiple advances at the discretion of the Company and will bear interest at a rate of 8% per year, payable monthly. The outstanding principal and any accrued interest may be prepaid without penalty and is to be fully repaid on the second anniversary of the first advance.

18


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)


As of October 31, 2018, the principal balance of the loan payable was $1,000,000. This balance is to be repaid on or before October 11, 2020. During the three and six months ended October 31, 2018, the Company recognized $4,603 and $4,603, respectively, in interest expense in the consolidated statement of operations. See Note 9 – Related Party Transactions .

   
Note 8

Common Stock

   
 

Private Placement

   

On July 20, 2017, the Company issued an aggregate of 539,240 shares of common stock under a non- brokered private placement at a price of $2.20 per share for total gross proceeds of $1,186,328 less issuance costs of $19,832. There were no private placements during the six months ended October 31, 2018.

   
 

Shares Issued for Services

   

On October 16, 2017, the Company entered into an agreement to issue 14,000 shares of the Company’s common stock in exchange for investor relation services. The agreement was terminated on April 8, 2018 as the services were no longer required. Pursuant to the terms of the agreement, upon termination, 7,211 shares of common stock were returned to the Company.

   
 

Stock Options

   

During the six months ended October 31, 2018, the Company granted 7,500 stock options to an employee of the Company. No stock options were granted in the same period in the prior year. The weighted-average fair value of options granted during the six months ended October 31, 2018 was $1.41. The weighted-average assumptions utilized to determine such value is presented in the following table:


    Six Months Ended
    October 31, 2018
  Risk-free interest rate 2.86%
  Expected volatility 76.3%
  Expected term 3.7 years
  Dividend yield 0%

During the six months ended October 31, 2018, the Company issued 6,958 shares pursuant to cashless exercises of 35,500 stock options and remitted employee tax withholdings of approximately $2,386 on the behalf of its employees. No stock options were exercised in the same periods in the prior year. The following is a summary of the status of the Company’s stock options as of October 31, 2018 and the stock option activity during the three and six months ended October 31, 2018:

      Weighted Average  
      Number of     Exercise Price  
      Options     per Share  
  Outstanding at April 30, 2018   675,042   $  2.66  
  Granted   7,500   $  2.51  
  Forfeited/Cancelled   (109,770 ) $  2.78  
  Expired   (11,000 ) $  2.50  
  Exercised   (35,500 ) $  2.50  
  Outstanding at October 31, 2018   526,272   $  2.65  
               
  Exercisable at October 31, 2018   294,335   $  2.56  
  Exercisable at April 30, 2018   256,555   $  2.47  

19


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)

Employee and non-employee stock-based compensation amounts classified in the Company’s consolidated statements of operations for the three and six months ended October 31, 2018 and 2017 are as follows:

      Three Months Ended     Six Months Ended  
      October 31,     October 31,  
      2018     2017     2018     2017  
  Cost of sales $  11,001   $  8,505   $  25,570   $  27,855  
  Sales and marketing   16,278     15,944     38,760     41,674  
  Research and development   10,983     11,527     26,014     31,927  
  General and administrative   18,076     36,099     44,723     72,348  
  Total stock-option based compensation   56,338   $  72,075   $  135,067   $  173,804  

Employee Stock Purchase Plan

Under the terms of the Employee Stock Purchase Plan (the “ESPP”) all regular salaried (non-probationary) employees can purchase up to 6% of their base salary in shares of the Company’s common stock at market price. The Company matches 50% of the shares purchased by issuing or purchasing in the market up to 3% of the respective employee’s base salary in shares. During the six months ended October 31, 2018, the Company matched $14,951 (2017 - $14,971) in shares purchased by employees under the ESPP. During the six months ended October 31, 2018, 12,984 shares (2017 – nil shares) were purchased on the open market and 5,656 shares (2017 – 12,165) were issued from treasury under the ESPP.

A total of 220,000 shares have been reserved for issuance under the ESPP. As of October 31, 2018, a total of 59,332 shares were available for issuance under the ESPP.

Deferred Share Unit Plan

During the three and six months ended October 31, 2018, 136,981 (2017 — 113,252) deferred stock units (DSUs) were issued under the Deferred Stock Unit Plan (DSUP), of which 68,491 were granted to officers or employees and 68,490 were granted to non-employee directors. As of October 31, 2018, a total of 142,496 shares were available for issuance under the DSUP.

The following table summarizes the Company’s outstanding DSU awards as of October 31, 2018, and changes during the period then ended:

            Weighted  
            Average Grant  
            Date Fair  
      Number of DSUs     Value Per DSU  
  DSUs outstanding at April 30, 2018   465,390   $  6.40  
  Granted   136,981   $  2.51  
  Cancelled   (68,880 ) $  2.42  
  DSUs outstanding at October 31, 2018   533,491   $  5.51  

20


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)

Employee and non-employee DSU based compensation amounts classified in the Company’s consolidated statements of operations for the three and six months ended October 31, 2018 and 2017 are as follows:

      Three Months Ended     Six Months Ended  
      October 31,     October 31,  
      2018     2017     2018     2017  
  General and administrative $  15,848   $ 38,552   $  204,530   $ 233,155  

  Normal Course Issuer Bid Plan
   

Pursuant to a normal course issuer bid (“NCIB”) commencing on March 29, 2017 and expired March 28, 2018, the Company was authorized to purchase 258,613 shares of the Company’s common stock through the facilities of the Toronto Stock Exchange (the “TSX”) and other Canadian marketplaces or U.S. marketplaces. During the period March 29, 2017 to October 31, 2017, the Company repurchased 73,500 common shares at an average price of $2.17 (CDN$2.81) for a total of $159,495. As of October 31, 2017, a total of 71,500 shares had been cancelled and another 2,000 repurchased shares were in the process of being cancelled.

   

On March 27, 2018, the Company filed another normal course issuer bid commencing on March 29, 2018 and expiring March 28, 2019. Under this normal course issuer bid, the Company is authorized to purchase up to 284,278 shares of its common stock through the facilities of the TSX and other Canadian marketplaces or U.S. marketplaces. During the three and six months ended October 31, 2018, no shares were repurchased under the NCIB.

   
Note 9

Related Party Transactions

   

On October 10, 2018, the Company entered into a loan agreement (the “Loan Agreement”) with Wesley Clover International Corporation, a company controlled by the Chairman of the Company, and KMB Trac Two Holdings Ltd., a company owned by the spouse of a director of the Company. As of October 31, 2018, the principal balance of the loan payable was $1,000,000. During the three and six months ended October 31, 2018, the Company recognized $4,603 and $4,603, respectively, in interest expense in the consolidated statement of operations. See Note 7 – Loan Payable for more information.

   

During the three and six months ended October 31, 2018, the Company through its wholly owned subsidiary, CounterPath Technologies, paid $20,947 and $42,065 (2017 - $20,078 and $40,156), respectively, to KRP Properties (“KRP”) (previously known as Kanata Research Park Corporation) for leased office space. KRP is controlled by the Chairman of the Company.

   

On November 21, 2013, the Company, through its wholly owned subsidiary, CounterPath Technologies, entered into an agreement with 8007004 (Canada) Inc. (“8007004”) to lease office space. 8007004 is controlled by a member of the board of directors of the Company. CounterPath Technologies, paid $7,734 and $15,530 (2017 - $7,907 and $15,836) for the three and six months ended October 31, 2018, respectively.

   

On July 20, 2017, our Company issued an aggregate of 539,240 shares of common stock under a non- brokered private placement at a price of $2.20 per share for total gross proceeds of $1,186,328 less issuance costs of $19,832. In connection with this private placement, Wesley Clover International Corporation purchased 144,357 shares, KMB Trac Two Holdings Ltd., purchased 180,446 shares, the chief executive officer and a director of the Company, purchased 11,368 shares, the chief financial officer of the Company, purchased 4,511 shares, and the executive vice president, sales and marketing of the Company, purchased 4,545 shares.

   

The above transactions are in the normal course of operations and are recorded at amounts established and agreed to between the related parties.

21


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)


Note 10 Segmented Information
   

The Company’s chief operating decision maker reviews financial information presented on a consolidated basis, accompanied by disaggregated information about revenues by geographic region for purposes of making operating decisions and assessing financial performance. Accordingly, the Company has concluded that it has one reportable operating segment.

   

Revenues are categorized based on the country in which the customer is located. The following is a summary of total revenues by geographic area for the three and six months ended October 31, 2018 and 2017:


      Three Months Ended     Six Months Ended  
      October 31,     October 31,  
      2018     2017     2018     2017  
  North America $  1,642,703   $  1,755,522   $  3,381,006   $  3,509,598  
  EMEA   570,487     1,239,538     1,212,481     2,183,667  
  Asia Pacific   135,635     223,512     551,660     521,895  
  Latin America   92,436     191,993     183,944     308,211  
    $  2,441,261   $  3,410,565   $  5,329,091   $  6,523,371  

All of the Company’s long-lived assets, which include equipment, goodwill and intangible assets and other assets, are located in Canada and the United States as follows:

      October 31,     April 30,  
      2018     2018  
  Canada   6,969,958     7,150,537  
  United States   35,736     35,919  
  $ 7,005,694   $ 7,186,456  

Note 11 Commitments
   
  Total payable over the term of the agreements for the period ended are as follows:

      Office     Office           Voice        
      Leases –     Leases –     Total     Platform     Software  
      Related     Unrelated     Office     Service     Development  
      Party     Party     Leases     Contract     Contract  
  2019 $  56,078   $  290,364   $  346,442   $  110,000   $  132,750  
  2020   5,156     305,178     310,334     240,000      
  2021       41,331     41,331     220,000      
  2022       24,110     24,110          
    $  61,234   $  660,983   $  722,217   $  570,000   $  132,750  

Note 12 Contingencies
   

The Company is party to legal claims from time to time which arise in the normal course of business. These claims are not expected to have a material adverse effect on the financial position, results of operations or cash flows of the Company.

22


COUNTERPATH CORPORATION
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS
October 31, 2018
(Unaudited)


Note 13 Loss per share
   
  The following table shows the computation of basic and diluted loss per share:

      Three Months Ended     Six Months Ended  
      October 31,     October 31,  
      2018     2017     2018     2017  
  Numerator                        
     Net income (loss) $  (2,063,757 ) $  158,834   $  (3,074,704 ) $ (993,699 )
                           
  Denominator                        
     Weighted average shares outstanding   5,941,812     5,487,765     5,937,115     5,262,359  
     Effect of dilutive securities       404,815          
      5,941,812     5,892,580     5,937,115     5,262,359  
                           
  Basic and diluted loss per share $  (0.35 ) $  0.03   $  (0.52 ) $ (0.19 )

For the three months ended October 31, 2018, common share equivalents consisting of stock options and DSUs totaling 1,059,763 were not included in the computation of diluted EPS because the effect was anti-dilutive. For the three months ended October 31, 2017, common share equivalents consisting of 3,677 options and 401,138 DSUs were included in the computation of diluted EPS because the effect was dilutive. For the six months ended October 31, 2018 and 2017, common share equivalents consisting of stock options and DSUs totaling 1,059,763 and 820,886, respectively, were not included in the computation of diluted EPS because the effect was anti-dilutive.

23


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

            This quarterly report, including the documents incorporated herein and therein by reference, contains forward-looking statements as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the United States Securities Exchange Act of 1934. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of these terms or other comparable terminology. Forward-looking statements in this quarterly report may include statements about:

  • any potential loss of or reductions in orders from certain significant customers;

  • our dependence on our customers to sell our applications or services using our applications;

  • our ability to protect our intellectual property;

  • competitive factors, including, but not limited to, industry consolidation, entry of new competitors into our market, and new product and marketing initiatives by our competitors;

  • our ability to predict our revenue, operating results and gross margin accurately;

  • the length and unpredictability of our sales cycles;

  • our ability to expand or enhance our product offerings including in response to industry demands or market trends;

  • our ability to sell our products in certain markets;

  • our ability to manage growth;

  • the attraction and retention of qualified employees and key personnel;

  • the interoperability of our products with service provider networks; and

  • the quality of our products and services, including any undetected errors or bugs in our software.

            These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks in the section entitled “Risk Factors”, that may cause our company's or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

            Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including securities laws of the United States of America and Canada, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

References

            In this quarterly report, (i) unless the context otherwise requires, references to “we”, “our”, “us”, the “Company” or “CounterPath” mean CounterPath Corporation and its subsidiaries and (ii) all amounts are expressed in United States dollars, unless otherwise indicated.

Background

                We were incorporated under the laws of the State of Nevada on April 18, 2003.

24


            On August 2, 2007, we acquired all of the shares of NewHeights Software Corporation through the issuance of 768,017 shares of our common stock and 36,984 preferred shares issued from a subsidiary of our company, which preferred shares were exchangeable into 36,984 shares of common stock.

            On February 1, 2008, we acquired all of the shares of FirstHand Technologies Inc. through the issuance of 590,001 shares of our common stock. On February 1, 2008, we acquired all of the issued and outstanding shares of BridgePort Networks, Inc. (“BridgePort Networks”) by way of merger in consideration for the assumption of all of the assets and liabilities of BridgePort Networks.

Business of CounterPath

            We design, develop and sell software and services that enable enterprises and telecommunication service providers to deliver Unified Communications (UC) services, including voice, video, messaging and collaboration functionality, over their Internet Protocol, or IP, based networks. We are capitalizing upon numerous industry trends, including the rapid adoption of mobile technology, the proliferation of bring-your-own-device to work programs, the need for secure business communications, the need for centralized provisioning, the migration towards cloud-based services and the migration towards all IP networks. We are also capitalizing on a trend where communication services such as Skype and WhatsApp are becoming more available over-the-top (OTT) of the incumbent operators’ networks or enterprise networks (a.k.a. Internet OTT providers). We offer our solutions under perpetual license agreements that generate one-time license revenue and under subscription license agreements that generate recurring license revenue. We sell our solutions through our own online store, through third-party online stores, directly using our in-house sales team and through channel partners. Our channel partners include original equipment manufacturers, value added distributers and value added resellers. Enterprises typically leverage our Enterprise OTT solutions to increase employee productivity and to reduce certain costs. Telecommunication service providers typically deploy our Operator OTT solutions as part of a broad strategy to defend their subscriber base from competitive threats by offering innovative new services. Our original equipment manufacturers and value added resellers typically integrate our solutions into their products and then sell a bundled solution to their end customers, which include both telecommunication service providers and enterprises.

Revenue

            Our total revenue consists of the following:

  • Software

    We generate software revenue primarily on a single fee per perpetual software license basis. We recognize software revenue for perpetual licenses when control has transferred to the customer, which is generally at the time of delivery, provided all revenue recognition criteria have been met. If the revenue recognition criteria have not been met, the revenue is deferred or not recognized. The number of software licenses purchased has a direct impact on the average selling price. Our software revenue may vary significantly from quarter to quarter as a result of long sales and deployment cycles, new product introductions and variations in customer ordering practices.

  • Subscription, support and maintenance

    We generate recurring subscription revenue from subscriptions related to our software as a service offering. Recurring support and maintenance revenue is generated from annual software support and maintenance contracts for our perpetual software licenses. Support and maintenance revenue is typically billed annually in advance based on the terms of the arrangement, while subscription revenue is typically billed annually or monthly in advance based on the terms of the agreement.

    Support and maintenance services include e-mail and telephone support, unspecified rights to bug fixes and product updates and upgrades and enhancements available on a when-and-if available basis, and are recognized rateably over the term of the service period, which is generally twelve months.

25


  • Professional services and other

    We generate professional services and other revenue through services including product configuration and customization, implementation, dedicated engineering and training. The amount of product configuration and customization required by a customer typically increases as the order size increases from a given customer. Services and pricing may vary depending upon a customer's requirements for customization, implementation and training.

Operating Expenses

            Operating expenses consist of cost of sales, sales and marketing, research and development, and general and administrative expenses. Personnel-related costs are the most significant component of each of these expense categories.

            Cost of sales primarily consists of: (a) salaries and benefits related to personnel, (b) related overhead, (c) billable and non-billable travel, lodging, and other out-of-pocket expenses, (d) payments to third party vendors for development and hosted services and compression/decompression software known as codecs, (e) amortization of capitalized software that is implemented into our products and (f) warranty expense.

            Sales and marketing expense consists primarily of: (a) salaries and related personnel costs including stock-based compensation, (b) commissions, (c) travel, lodging and other out-of-pocket expenses, (d) marketing programs such as advertising, promotions and trade shows and (e) other related overhead. Commissions are considered incremental and recoverable costs of acquiring customer contracts. These costs are capitalized and amortized on a systematic basis to sales and marketing expense, over the anticipated benefit period of up to 3.5 years depending on the products or services. Sales commissions on contracts with an anticipated benefit period of one year or less are expensed as incurred. We expect increases in sales and marketing expense for the foreseeable future as we further increase the number of sales professionals and increase our marketing activities with the intent to grow our revenue. We expect sales and marketing expense to decrease as a percentage of total revenue, however, as we leverage our current sales and marketing personnel as well as our distribution partnerships.

            Research and development expense consists primarily of: (a) salaries and related personnel costs including stock-based compensation, (b) payments to contractors for design and consulting services, (c) costs relating to the design and development of new products and enhancement of existing products, (d) quality assurance and testing and (e) other related overhead. To date, all of our research and development costs have been expensed as incurred.

            General and administrative expense consists primarily of: (a) salaries and personnel costs including stock-based compensation related to our executive, finance, human resource and information technology functions, (b) accounting, legal, tax advisory and regulatory fees and (c) other related overhead.

Application of Critical Accounting Policies and Use of Estimates

            Our interim consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires that we make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ significantly from these estimates under different assumptions or conditions. There have been no material changes to these estimates for the periods presented in this quarterly report.

            There have been no significant changes to our critical accounting policies and estimates previously disclosed in our Form 10-K for the fiscal year ended April 30, 2018, during the six months ended October 31, 2018 except for our adoption of ASC 606 as described below:

26


Revenue Recognition

            On May 1, 2018, we adopted the new accounting standard, ASC 606 “Revenue from Contracts with Customers” and all related amendments to the new accounting standard to contracts using the modified retrospective method. We recognized the cumulative effect of initially applying the new revenue recognition standard to contracts with open performance obligations as of May 1, 2018, as an adjustment to the opening balance of retained earnings. Results of the reporting period beginning May 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under ASC 605.

            Revenues from contracts with customers are recognized when control of promised goods and services is transferred to customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.

            We recognize revenue using the five-step model as prescribed by ASC 606:

  1)

Identification of the contract, or contracts, with a customer;

  2)

Identification of the performance obligations in the contract;

  3)

Determination of the transaction price;

  4)

Allocation of the transaction price to the performance obligations in the contract; and

  5)

Recognition of revenue when or as, we satisfy a performance obligation.

            When a contract with a customer is signed, we assess whether collection of the fees under the arrangement is probable. We estimate the amount to reserve for uncollectible amounts at the end of each reporting period based on the aging of the contract balance, current and historical customer trends, and communications with its customers. These reserves are recorded against the related accounts receivable.

            The transaction price is the consideration that we expect to receive from our customers in exchange for our products and services. In determining the allocation of the transaction price, we identify performance obligations in contracts with customers, which may include products, subscriptions to software and services, support, professional services and training. We allocate the transaction price to each performance obligation on a relative standalone selling price basis. The standalone selling price (SSP) is the price at which we would sell a promised product or service separately to a customer. We determine the SSP using information that may include market conditions or other observable inputs. In certain cases, we are able to establish a SSP based on observable prices for products or services sold separately. In these instances, we would use a single amount to estimate a SSP. If a SSP is not directly observable, for example when pricing is variable, we will use a range of SSP.

            In certain circumstances, we may estimate SSP for a product or service by applying the residual approach. This approach has been most commonly used when certain perpetual software licenses are only sold bundled with one year of post-contract support or other services and a price has not been established for the software.

            Significant judgement is used to determine SSP and to determine whether there is a variance that needs to be allocated based on the relative SSP of the various products and services. Estimating SSP is a formal process that includes review and approval by management.

            We recognize software revenue for perpetual licenses when control has transferred to the customer, which is generally at the time of delivery when the customer has the ability to deploy the licenses, provided all revenue recognition criteria have been met. If the revenue recognition criteria has not been met, the revenue is deferred or not recognized.

            We recognize revenue from subscriptions related to our software as a service offering ratably over the contractual subscription term as control of the goods or services is transferred to the customer, beginning on the date that the subscription is made available to the customer. Support and maintenance revenue is generated from recurring annual software support and maintenance contracts for our perpetual software licenses and is recognized ratably over the term of the service period, which is generally twelve months. Support and maintenance services include e-mail and telephone support, unspecified rights to bug fixes and product updates and upgrades and enhancements available on a when-and-if available basis. Both subscription revenue and support and maintenance revenue are typically billed annually in advance based on the terms of the arrangement.

27


            We recognize revenue from professional services and other revenue when control has transferred to the customer, which is generally at the time of delivery, and all other revenue recognition criteria have been met. For contracts with elements related to customized network solutions and certain network build-outs or software systems that require significant modification or customization, we will recognize revenue using the percentage-of-completion method. In using the percentage-of-completion method, revenues are generally recorded based on completion of milestones as described in the agreement. Profit estimates on long-term contracts are revised periodically based on changes in circumstances and any losses on contracts are recognized in the period that such losses become known. Depending on the services to be provided, revenue from professional services and other is generally recognized at the time of delivery when the services have been completed and control has been transferred to the customer.

Unearned Revenue

            Unearned revenue represent billings or payments received in advance of revenue recognition and is recognized upon transfer of control. Balances consist primarily of annual support and subscription services and professional and training services not yet provided as of the balance sheet date.

Costs to Obtain a Customer Contract

            Sales commissions and related expenses are considered incremental and recoverable costs of acquiring customer contracts. These costs are capitalized and amortized on a systematic basis to match the timing of revenue recognition over the anticipated benefit period of up to 3.5 years depending on the products and services. The anticipated benefit period was estimated based on the average length of applicable customer contracts and includes the contract term and any anticipated renewal periods. This amortization expense is recorded in sales and marketing expense within the Company's consolidated statement of operations. The Company has elected to apply a practical expedient that permits the Company to expense costs to obtain a contract as incurred, if the anticipated benefit period is one year or less. From time to time, management will revisit the estimates used in recognizing the costs to obtain customer contracts.

Costs to Fulfill a Customer Contract

Certain contract costs incurred to fulfill obligations under a contract are capitalized when such costs generate or enhance resources to be used in satisfying future performance obligations and the costs are deemed recoverable. Judgement is used in determining whether certain contract costs can be capitalized. These costs are capitalized and amortized on a systematic basis to match the timing of revenue recognition over the anticipated benefit period of up to 3.5 years, depending on the products and services. The anticipated benefit period was estimated based on the average length of applicable customer contracts and includes the contract term and any anticipated renewal periods. This amortization expense is recorded in cost of sales in the Company’s consolidated statement of operations. From time to time, management will review the capitalized costs for impairment and will also revisit the estimates used in recognizing the costs to fulfill customer contracts.

Results of Operations

            Our operating activities during the three and six months ended October 31, 2018 consisted primarily of selling our IP telephony software and related services to telecom service providers, enterprises and channel partners serving the telecom and enterprise segments, and the continued development of our IP telephony software products.

            We generate our revenue primarily in U.S. dollars and incur a majority of our expenses in Canadian dollars. As a result of the fluctuation in the Canadian dollar against the U.S. dollar over the three and six months ended October 31, 2018, we recorded decrease operating costs on translation of Canadian dollar costs as compared to the three and six months ended October 31, 2017 of approximately $59,400 and $86,300, respectively.

28


Selected Consolidated Financial Information

            The following tables set out selected consolidated unaudited financial information for the periods indicated. The selected consolidated financial information set out below for the three and six months ended October 31, 2018 and 2017 has been derived from the consolidated unaudited financial statements and accompanying notes for the three and six months ended October 31, 2018 and 2017 and the audited consolidated financial statements for the fiscal year ended April 30, 2018. Each investor should read the following information in conjunction with those statements and the related notes thereto.

Selected Consolidated Statements of Operations Data

    Three Months Ended October 31,  
    2018     2017  
          Percent of           Percent  
          Total           of Total  
    Amount     Revenue     Amount     Revenue  
Revenue $ 2,441,261     100%   $ 3,410,565     100%  
                         
Operating expenses   4,533,338     186%     3,456,084     101%  
Loss from operations   ($2,092,077 )   (86% )   ($45,519 )   (1% )
Interest and other income, net   (4,661 )   −%     (162 )   −%  
Foreign exchange gain (loss)   43,535     1%     204,515     6%  
Loss on change in fair value of derivative instruments   (10,554 )   −%         −%  
Net income (loss)   ($2,063,757 )   (85% ) $ 158,834     5%  
                         
Net income (loss) per share                        
-Basic   ($0.35 )       $ 0.03        
-Diluted   ($0.35 )       $ 0.03        
Weighted average common shares outstanding                        
-Basic   5,941,812           5,487,765        
-Diluted   5,941,812           5,892,580        

Selected Consolidated Statements of Operations Data

    Six Months Ended October 31,  
    2018     2017  
          Percent of           Percent  
          Total           of Total  
    Amount     Revenue     Amount     Revenue  
Revenue $ 5,329,091     100%   $ 6,523,371     100%  
                         
Operating expenses   8,518,448     160%     7,102,671     109%  
Loss from operations   ($3,189,357 )   (60% )   ($579,300 )   (9% )
Interest and other income, net   (4,666 )   −%     (215 )   −%  
Foreign exchange gain (loss)   124,471     2%     (414,184 )   (6% )
Loss on change in fair value of derivative instruments   (5,152 )   −%         −%  
Net loss   ($3,074,704 )   (58% )   ($993,699 )   (15% )
                         
Net loss per share                        
-Basic and diluted   ($0.52 )         ($0.19 )      
Weighted average common shares outstanding                        
-Basic and diluted   5,937,115           5,262,359        

29



Revenue                                    
                                     
  Three Months Ended October 31,                    
    2018     2017     Period-to-Period Change  
          Percent           Percent           Percent  
          of Total           of Total           Increase /  
    Amount     Revenue     Amount     Revenue     Amount     (Decrease)  
  Revenue by Type                                    
 Software $ 923,416     38%   $ 1,816,867     53%     ($893,451 )   (49% )
 Subscription, support and maintenance   1,319,840     54%     981,619     29%     338,221     34%  
 Professional services and other   198,005     8%     612,079     18%     (414,074 )   (68% )
 Total revenue $ 2,441,261     100%   $ 3,410,565     100%     ($969,304 )   (28% )
                                     
  Revenue by Region                                    
   North America $ 1,642,703     67%   $ 1,755,522     51%     ($112,819 )   (6% )
   International   798,558     33%     1,655,043     49%     (856,485 )   (52% )
 Total revenue $ 2,441,261     100%   $ 3,410,565     100%     ($969,304 )   (28% )

            For the three months ended October 31, 2018, we generated $2,441,261 in revenue compared to $3,410,565 for the three months ended October 31, 2017, representing a decrease of $969,304 or 28%.

            Software revenue decreased by $893,451 or 49% to $923,416 for the three months ended October 31, 2018 compared to $1,861,867 for the three months ended October 31, 2017. The decrease in software revenue was a result of decreased sales to channel partners, service providers, and enterprises.

            Subscription, support and maintenance revenue increased by $338,221 or 34% to $1,319,840 for the three months ended October 31, 2018 compared to $981,619 for the three months ended October 31, 2017. The increase in subscription, support and maintenance revenue was a result of increased sales to channel partners, and service providers.

            Professional services and other revenue decreased by $414,074 or 68% to $198,005 for the three months ended October 31, 2018 compared to $612,079 for the three months ended October 31, 2017. The decrease in professional services and other revenue was a result of decreased sales to service providers and channel partners.

            North American revenue decreased by $112,819 or 6% to $1,642,703 for the three months ended October 31, 2018 compared to $1,755,522 for the three months ended October 31, 2017, as a result of lower sales of software to channel partners partially offset by higher sales of service to channel partners and service providers. International revenue outside of North America decreased by $856,485 or 52% to $798,558 for the three months ended October 31, 2018 compared to $1,655,043 for the three months ended October 31, 2017, as a result of lower sales of software and service to international service providers, channel partners, and enterprises.

  Six Months Ended October 31,                 
    2018     2017     Period-to-Period Change  
          Percent           Percent           Percent  
          of Total           of Total           Increase /  
    Amount     Revenue     Amount     Revenue     Amount     (Decrease)  
Revenue by Type                                    
Software $ 2,279,418     43%   $ 3,515,760     54%     ($1,236,342 )   (35% )
Subscription, support and maintenance   2,570,860     48%     1,948,681     30%     622,179     32%  
Professional services and other   478,813     9%     1,058,930     16%     (580,117 )   (55% )
Total revenue $ 5,329,091     100%   $ 6,523,371     100%     ($1,194,280 )   (18% )
Revenue by Region                                    
 North America $ 3,381,006     63%   $ 3,509,598     54%     ($128,592 )   (4% )
 International   1,948,085     37%     3,013,773     46%     (1,065,688 )   (35% )
Total revenue $ 5,329,091     100%   $ 6,523,371     100%     ($1,194,280 )   (18% )

30



            For the six months ended October 31, 2018, we generated $5,329,091 in revenue compared to $6,523,371 for the six months ended October 31, 2017, representing a decrease of $1,194,280 or 18%.

            Software revenue decreased by $1,236,342 or 35% to $2,279,418 for the six months ended October 31, 2018 compared to $3,515,760 for the six months ended October 31, 2017. The decrease in software revenue was a result of decreased sales to service providers, channel partners, and enterprises.

            Subscription, support and maintenance revenue increased by $622,179 or 32% to $2,570,860 for the six months ended October 31, 2018 compared to $1,948,681 for the six months ended October 31, 2017. The increase in subscription, support and maintenance revenue was a result of increased sales to channel partners and service providers.

            Professional services and other revenue decreased by $580,117 or 55% to $478,813 for the six months ended October 31, 2018 compared to $1,058,930 for the six months ended October 31, 2017. The decrease in professional services and other revenue was a result of decreased sales to service providers and channel partners.

            North American revenue decreased by $128,592 or 4% to $3,381,006 for the six months ended October 31, 2018 compared to $3,509,598 for the six months ended October 31, 2017, as a result of lower sales of software to enterprises, service providers, and channel partners partially offset by higher sales of service to channel partners and service providers. International revenue outside of North America decreased by $1,065,688 or 35% to $1,948,085 for the six months ended October 31, 2018 compared to $3,013,773 for the six months ended October 31, 2017, as a result of lower sales of software and service to European service providers and channel partners.

Operating Expenses

Cost of Sales

            Cost of sales for the three and six months ended October 31, 2018 and 2017 were as follows:

    October 31, 2018     October 31, 2017     Period-to-Period Change  
          Percent           Percent           Percent  
          of Total           of Total           Increase /  
    Amount     Revenue     Amount     Revenue     Amount     (Decrease)  
Three months ended $ 623,811     26%   $ 380,822     11%   $ 242,989     64%  
Six months ended $ 1,219,367     23%   $ 769,065     12%   $ 450,302     59%  

            Cost of sales was $623,811 for the three months ended October 31, 2018 compared to $380,822 for the three months ended October 31, 2017. The increase of $242,989 or 64% was primarily attributable to an increase in third-party service fees of approximately $160,700, wages and benefits expenses of approximately $67,200, an increase in licenses and software expense of approximately $37,000, offset by a decrease in other expenses of approximately $17,400.

            Cost of sales was $1,219,367 for the six months ended October 31, 2018 compared to $769,065 for the six months ended October 31, 2017. The increase of $450,302 or 59% was primarily attributable to an increase in third-party service fees of approximately $274,000, wages and benefits expenses of approximately $93,100, an increase in licenses and software expense of approximately $93,600, offset by a decrease in other expenses of approximately $10,400.

31


Sales and Marketing

            Sales and marketing expenses for the three and six months ended October 31, 2018 and 2017 were as follows:

    October 31, 2018     October 31, 2017     Period-to-Period Change  
          Percent           Percent           Percent  
          of Total           of Total           Increase /  
    Amount     Revenue     Amount     Revenue     Amount     (Decrease)  
Three months ended $ 967,689     40%   $ 1,031,227     30%     ($63,538 )   (6% )
Six months ended $ 1,962,649     37%     2,035,511     31%     ($72,862 )   (4% )

            Sales and marketing expenses were $967,689 for the three months ended October 31, 2018 compared to $1,031,227 for the three months ended October 31, 2017. The decrease of $63,538 or 6% was primarily attributable to a decrease in wages, benefits and consulting fees of approximately $77,300, offset by an increase in other expenses of approximately $13,700.

            Sales and marketing expenses were $1,962,649 for the six months ended October 31, 2018 compared to $2,035,511 for the six months ended October 31, 2017. The decrease of $72,862 or 4% was primarily attributable to a decrease wages, benefits and consulting fees of approximately $83,600 and a decrease in marketing expenses of approximately $34,500. This decrease was offset by an increase in travel and trade show expenses of approximately $9,300 and an increase in other expenses of approximately $35,900.

Research and Development

            Research and development expenses for the three and six months ended October 31, 2018 and 2017 were as follows:

    October 31, 2018     October 31, 2017     Period-to-Period Change  
          Percent           Percent           Percent  
          of Total           of Total           Increase /  
    Amount     Revenue     Amount     Revenue     Amount     (Decrease)  
Three months ended $ 1,391,737     57%   $ 1,329,437     39%   $ 62,300     5%  
Six months ended $ 2,794,693     52%   $ 2,690,910     41%   $ 103,783     4%  

            Research and development expenses were $1,391,737 for the three months ended October 31, 2018 compared to $1,329,437 for the three months ended October 31, 2017. The increase of $62,300 or 5% was primarily attributable to an increase in wages, benefits and consulting fees of approximately $41,100, and an increase in other expenses of approximately $21,200.

            Research and development expenses were $2,794,693 for the six months ended October 31, 2018 compared to $2,690,910 for the six months ended October 31, 2017. The increase of $103,783 or 4% was primarily attributable to an increase in wages, benefits and consulting fees of approximately $57,700, and an increase in other expenses of approximately $46,100.

General and Administrative

            General and administrative expenses for the three and six months ended October 31, 2018 and 2017 were as follows:

    October 31, 2018     October 31, 2017     Period-to-Period Change  
          Percent           Percent           Percent  
          of Total           of Total           Increase /  
    Amount     Revenue     Amount     Revenue     Amount     (Decrease)  
Three months ended $ 1,550,101     63%   $ 714,598     21%   $ 853,503     117%  
Six months ended $ 2,541,739     48%   $ 1,607,185     25%   $ 934,554     58%  

32


            General and administrative expenses were $1,550,101 for the three months ended October 31, 2018 compared to $714,598 for the three months ended October 31, 2017. The increase of $853,503 or 117% in general and administrative expenses was primarily attributable to an increase in bad debts expense of $601,300, a one time accrual of $321,000 related to the departure of our former chief executive officer, an increase in audit, legal and other professional expenses of approximately $22,100, an increase in license and permits fees of approximately $105,700, an increase in other expenses of approximately $31,900, offset by a decrease in wages, benefits and consulting fees of approximately $171,800.

            General and administrative expenses were $2,541,739 for the six months ended October 31, 2018 compared to $1,607,185 for the six months ended October 31, 2017. The increase of $934,554 or 58% in general and administrative expenses was primarily attributable to an increase in bad debts expense of approximately $651,200, a one time accrual of $321,000 related to the departure of our former chief executive officer, an increase in audit, legal and other professional expenses of approximately $63,400, an increase in license and permit fees of approximately $107,800, an increase in other expenses of approximately $49,400, offset by a decrease in wages, benefits and consulting fees of approximately $183,600.

Interest and Other Income (Expense), Net

            Interest and other income (expense), net was $28,319 and $114,652, for the three and six months ended October 31, 2018, respectively, compared to $204,353 and ($414,399) for the same periods in the prior year and is primarily comprised of foreign exchange gains and losses realized during the period. Foreign exchange gain for the three and six months ended October 31, 2018 was $43,535 and $124,471, respectively, compared to a foreign exchange gain of $204,515 and a foreign exchange loss of $414,184 for the three months and six months ended October 31, 2017, respectively. The foreign exchange gain (loss) represents the gain (loss) on account of translation of the intercompany accounts of our subsidiary which maintains their records in Canadian dollars and transactional gains and losses. The foreign exchange gain (loss) includes the translation of quarterly intercompany transfer pricing invoices from our Canadian subsidiary to us.

Liquidity and Capital Resources

            The following is a summary of selected financial information as at the dates indicated:

Selected Consolidated Balance Sheet Data   October 31, 2018     April 30, 2018  
Cash $ 1,848,630   $ 2,348,883  
Current assets $ 4,374,743   $ 6,049,138  
Total assets $ 11,539,396   $ 13,334,227  
Current liabilities $ 5,185,271   $ 5,068,939  
Total liabilities $ 6,204,105   $ 5,093,041  

            As of October 31, 2018, we had $1,848,630 in cash compared to $2,348,883 as of April 30, 2018, representing a decrease of $500,253. Our working capital deficit was $810,528 at October 31, 2018 compared to working capital of $980,199 at April 30, 2018, representing a decrease of $1,790,727.

            We have experienced recurring losses and an accumulated deficit of $66,642,356 as of October 31, 2018, as a result of flat to declining revenues resulting from a number of factors including our buildout of a cloud based subscription platform concurrent with the change of our licensing model to subscription based licensing and has not reached profitable operations which raises substantial doubt about its ability to continue operating as a going concern within one year of the date of issuance of the consolidated financial statements.

            To alleviate this situation, we have plans in place to improve our financial position and liquidity, while executing on our growth strategy, by managing and or reducing costs that is not expected to have an adverse impact on the ability to generate cash flows, as the transition to our software as a service platform and subscription licensing continues.

33


     We have historically been able to manage liquidity requirements through cost management and cost reduction measures, supplemented with raising additional financing. During the quarter ended October 31, 2018, we entered into a loan agreement for an aggregate principal amount of up to $3,000,000. As of October 31, 2018, the principal balance of the loan payable was $1,000,000. We do not have any other commitments to raise funds as of the date of issuance of this quarterly report on Form 10-Q.

            Our company has $1,326,893 in cash held outside of the United States, and there is no intent to repatriate such cash at this time. Should we decide to repatriate such cash in the future, taxes would need to be accrued and paid.

Cash Flows

            Our cash flows for the six months ended October 31, 2018 and 2017 are as follows:

    Six months ended     Six months ended  
    October 31, 2018     October 31, 2017  
Net cash used in operating activities   ($1,481,323 )   ($1,527,624 )
Net cash used in investing activities   ($21,283 )   ($62,403 )
Net cash provided by financing activities $ 1,010,439   $ 1,162,556  
Net decrease in cash   ($500,253 )   ($388,887 )

Operating Activities

            Our operating activities resulted in a net cash outflow of $1,481,323 for the six months ended October 31, compared to a net cash outflow of $1,527,624 for the same period in the prior year, representing a decrease in net cash used in operating activities of $46,301. The decrease in net cash used in operating activities for the six months ended October 31, 2018 was primarily due to an increase in the change in accounts receivables of approximately $2,952,400 and increases in accounts payable and accrued liabilities by approximately $60,500. These increases are offset by increases in net loss of approximately $2,081,005, non-cash foreign exchange gain of approximately $555,000 and stock-based compensation expense of approximately $67,400. The decrease in cash used in operating activities is also attributed to decreases in deferred sales commissions costs and unearned revenue of approximately $31,500 and $206,000, respectively.

Investing Activities

            Investing activities resulted in a net cash outflow of $21,283 for the six months ended October 31, 2018, compared to $62,403 for the same period in the prior year. The decrease in net cash outflow from investing activities was primarily a result of a decrease in investments in computer equipment and intangible assets. At October 31, 2018, we did not have any material commitments for future capital expenditures.

Financing Activities

            Financing activities resulted in a net cash inflow of $1,010,439 for the six months ended October 31, 2018 compared to a net cash inflow of $1,162,556 for the six months ended October 31, 2017. The decrease in net cash inflow from financing activities was primarily due to the private placement that occurred on July 20, 2017 where we issued an aggregate of 539,240 shares of common stock at a price of $2.20 per share for total gross proceeds of $1,186,328 less issuance costs of $19,832. During the six months ended October 31, 2018, we received proceeds of $1,000,000 under a loan agreement, in addition to proceeds received related shares issued pursuant to our employee stock purchase plan of approximately $10,400.

Off-Balance Sheet Arrangements

            We do not have, and do not have any present plans to implement, any off-balance sheet arrangements.

34


Recently Adopted Accounting Pronouncements

            In May 2014, FASB issued ASU 2014-09, Revenue From Contracts With Customers (“Topic 606”) which supersedes the revenue recognition requirements in Topic 605 “Revenue Recognition” (“Topic 605”) and requires entities to recognize revenue when control of the promised goods or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods and services. The Company adopted ASU 2014-09 as of May 1, 2018 using the modified retrospective transition method. See Note 4 – Revenue Recognition under ASC 606 in our notes to consolidated financial statements for further details.

Recently Issued Accounting Pronouncements

            In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities, which amends the presentation and disclosure requirements and changes how companies assess effectiveness. The amendments are intended to more closely align hedge accounting with companies’ risk management strategies, simplify the application of hedge accounting, and increase transparency as to the scope and results of hedging programs. This amendment is effective for annual periods beginning after December 15, 2018, including interim periods within those periods. Early application is permitted. We are currently assessing the future impact of this update on its consolidated financial statements and related disclosures.

            In January 2017, the FASB issued ASU 2017-04, Intangibles – Goodwill and Other: Simplifying the Test for Goodwill Impairment, which amends the guidance to eliminate Step 2 from the goodwill impairment test. Instead, under the amendments in the new guidance, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The amendments will be effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of this amendment on our consolidated financial statements and related disclosures.

            In June 2016, the FASB issued ASU 2016-13, Financial Instruments: Measurement of Credit Losses on Financial Instruments, which amends the guidance on measuring credit losses on financial assets held at amortized cost. The amendment is intended to address the issue that the previous “incurred loss” methodology was restrictive of our ability to record credit losses based on not yet meeting the “probable” threshold. The new language will require these assets to be valued at amortized cost presented at the net amount expected to be collected will a valuation provision. The amendments will be effective for fiscal years beginning after December 15, 2019. We are evaluating the impact of this amendment on our consolidated financial statements and related disclosures.

            In February 2016, FASB issued ASU 2016-02, “Leases” which would require lessees to recognize most leases on their balance sheets as lease liabilities with corresponding right-of-use assets. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2018. We are currently evaluating the impact of its pending adoption of ASU 2016-02 on our consolidated financial statements.

Item 3.         Quantitative and Qualitative Disclosures About Market Risk.

            Not Applicable.

Item 4.         Controls and Procedures.

Disclosure Controls and Procedures

            Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time period specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934 is accumulated and communicated to management including our Interim Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

35


            In connection with this quarterly report, as required by Rule 13a-15 under the Securities Exchange Act of 1934, we have carried out an evaluation of the effectiveness of the design and operation of our company's disclosure controls and procedures. This evaluation was carried out under the supervision and with the participation of our company's management, including our company's Interim Chief Executive Officer and Chief Financial Officer. Based upon that evaluation, our company's Interim Chief Executive Officer and Chief Financial Officer concluded that as of October 31, 2018, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

            There were no changes in our internal control over financial reporting that occurred during the quarter ended October 31, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

            None.

Item 1A. Risk Factors.

            Much of the information included in this quarterly report includes or is based upon estimates, projections or other “forward looking statements”. Such forward looking statements include any projections or estimates made by us and our management in connection with our business operations. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumption or other future performance suggested herein.

            Such estimates, projections or other “forward looking statements” involve various risks and uncertainties as outlined below. We caution the reader that important factors in some cases have affected and, in the future, could materially affect actual results and cause actual results to differ materially from the results expressed in any such estimates, projections or other “forward looking statements”.

Risks Associated with our Business and Industry

             Lack of cash flow which may affect our ability to continue as a going concern.

            Presently, our operating cash flows are not sufficient to meet operating and capital expenses. Our business plan calls for continued research and development of our products and expansion of our market share. We will require additional financing to fund working capital and pay for operating expenses and capital requirements until we achieve a positive cash flow.

            There is no assurance that actual cash requirements will not exceed our estimates. In particular, additional capital may be required in the event that:

  • we incur delays and additional expenses as a result of technology failure;

  • we are unable to create a substantial market for our products; or

  • we incur any significant unanticipated expenses.

36


            The occurrence of any of the aforementioned events could adversely affect our ability to meet our proposed business plans.

            We depend on a mix of revenues and outside capital to pay for the continued development of our technology and the marketing of our products. Such outside capital may include the sale of additional stock and/or commercial borrowing. There can be no assurance that capital will continue to be available if necessary to meet these continuing development costs or, if the capital is available, that it will be on terms acceptable to us. Disruptions in financial markets and challenging economic conditions have and may continue to affect our ability to raise capital. The issuance of additional equity securities by us would result in a dilution, possibly a significant dilution, in the equity interests of our current stockholders. Obtaining commercial loans, assuming those loans would be available, will increase our liabilities and future cash commitments.

             Our revenue, operating results and gross margin can fluctuate significantly and unpredictably from quarter-to-quarter and from year-to-year, and we expect that they will continue to do so, which could have a material adverse effect on our operating results.

            The rate at which our customers order our products, and the size of these orders, are highly variable and difficult to predict. In the past, we have experienced significant variability in our customer purchasing practices on a quarterly and annual basis, and we expect that this variability will continue, as a result of a number of factors, many of which are beyond our control, including:

  • demand for our products and the timing and size of customer orders;

  • length of sales cycles, which may be extended by selling our products through channel partners;

  • length of time of deployment of our products by our customers;

  • customers’ budgetary constraints;

  • competitive pressures; and

  • general economic conditions.

            As a result of this volatility in our customers’ purchasing practices, our revenue has historically fluctuated unpredictably on a quarterly and annual basis and we expect this to continue for the foreseeable future. Our budgeted expense levels depend in part on our expectations of future revenue. Because any substantial adjustment to expenses to account for lower levels of revenue is difficult and takes time, if our revenue declines, our operating expenses and general overhead would likely be high relative to revenue, which could have a material adverse effect on our operating margin and operating results.

             We may be unable to predict subscription renewal rates and the impact these rates may have on our future revenue and operating results.

            Some of our products and services are sold on a subscription basis that is generally month-to-month or one year in length. Our customers have no obligation to renew their subscriptions for our services after the expiration of their initial subscription period, and some customers elect not to renew. We cannot provide assurance that our subscriptions will be renewed at the same or higher level of service, for the same number of licenses or for the same duration of time, if at all. We cannot provide assurance that we will be able to accurately predict future customer renewal rates. Our customers’ renewal rates may decline or fluctuate as a result of a number of factors, including their level of satisfaction with our services, our ability to continue to regularly add features and functionality, the reliability (including uptime) of our subscription services, the prices of our services, the prices of services offered by our competitors, mergers and acquisitions affecting our customer base, reductions in our customers’ spending levels or declines in customer activity as a result of economic downturns or uncertainty in financial markets. If our customers do not renew their subscriptions for our services or if they renew on terms less favorable to us, our revenue may decline.

37


             If we are not able to manage our operating expenses, then our financial condition may be adversely affected.

            Operating expenses of $4,533,338 and $8,518,448 exceeded revenue by $2,092,077 and $3,189,357 for the three and six months ended October 31, 2018, respectively. Our ability to reach and maintain profitability is conditional upon our ability to manage our operating expenses. There is a risk that we will have to increase our operating expenses in the future. Factors that could cause our operating expenses to increase include our determination to spend more on sales and marketing in order to increase product sales or our determination that more research and development expenditures are required in order to keep our current software products competitive or in order to develop new products for the market. To the extent that our operating expenses increase without a corresponding increase in revenue, our financial condition would be adversely impacted.

             We face larger and better-financed competitors, which may affect our ability to achieve or maintain profitability.

            Management is aware of similar products which compete directly with our products and some of the companies developing these similar products are larger and better-financed than us and may develop products superior to those of our company. In addition to price competition, increased competition may result in other aggressive business tactics from our competitors, such as:

  • emphasizing their own size and perceived stability against our smaller size and narrower recognition;

  • providing customers “one-stop shopping” options for the purchase of network equipment and application software;

  • offering customers financing assistance;

  • making early announcements of competing products and employing extensive marketing efforts; and

  • asserting infringement of their intellectual property rights.

            Such competition may potentially adversely affect our profitability.

             A decline in the price of our common stock could affect our ability to raise further working capital and adversely impact our operations.

            A prolonged decline in the price of our common stock could result in a reduction in the liquidity of our common stock and a reduction in our ability to raise capital, or a delisting from a stock exchange on which our common stock trades. Because our operations have been partially financed through the sale of equity securities, a decline in the price of our common stock could be especially detrimental to our liquidity and our continued operations. Any reduction in our ability to raise equity capital in the future would force us to reallocate funds from other planned uses and would have a significant negative effect on our business plans and operations, including our ability to develop new products and continue our current operations. If our stock price declines, there can be no assurance that we can raise additional capital or generate funds from operations sufficient to meet our obligations.

             The majority of our directors and officers are located outside the United States, with the result that it may be difficult for investors to enforce within the United States any judgments obtained against us or some of our directors or officers.

            The majority of our directors and officers are nationals and/or residents of countries other than the United States, and all or a substantial portion of such persons' assets are located outside the United States. As a result, it may be difficult for investors to enforce within the United States any judgments obtained against us or our officers or directors, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state thereof. Consequently, investors may be effectively prevented from pursuing remedies under United States federal securities laws against some of our directors or officers.

38


             We may in the future be subject to damaging and disruptive intellectual property litigation that could materially and adversely affect our business, results of operations and financial condition, as well as the continued viability of our company.

            We may be unaware of filed patent applications and issued patents that could relate to our products and services. Intellectual property litigation, if determined against us, could:

  • result in the loss of a substantial number of existing customers or prohibit the acquisition of new customers;

  • cause us to lose access to key distribution channels;

  • result in substantial employee layoffs or risk the permanent loss of highly-valued employees;

  • materially and adversely affect our brand in the market place and cause a substantial loss of goodwill;

  • affect our ability to raise additional capital;

  • cause our stock price to decline significantly; and

  • lead to the bankruptcy or liquidation of our company.

            Parties making claims of infringement may be able to obtain injunctive or other equitable relief that could effectively block our ability to provide our products or services and could cause us to pay substantial royalties, licensing fees or damages. The defense of any lawsuit could result in time-consuming and expensive litigation, regardless of the merits of such claims.

             We could lose our competitive advantages if we are not able to protect any proprietary technology and intellectual property rights against infringement, and any related litigation could be time-consuming and costly.

            Our success and ability to compete depends to a significant degree on our proprietary technology incorporated in our software. If any of our competitors' copy or otherwise gain access to our proprietary technology or develops similar technologies independently, we would not be able to compete as effectively. We also consider our family of registered and unregistered trademarks including CounterPath, Bria, eyebeam, X-Lite, and Softphone.com invaluable to our ability to continue to develop and maintain the goodwill and recognition associated with our brand. The measures we take to protect the proprietary technology software, and other intellectual property rights, which presently are based upon a combination of patents, patents pending, copyright, trade secret and trademark laws, may not be adequate to prevent their unauthorized use. Further, the laws of foreign countries may provide inadequate protection of such intellectual property rights.

            We may need to bring legal claims to enforce or protect such intellectual property rights. Any litigation, whether successful or unsuccessful, could result in substantial costs and divert resources from intended uses. In addition, notwithstanding any rights we have secured in our intellectual property, other persons may bring claims against us that we have infringed on their intellectual property rights, including claims based upon the content we license from third parties or claims that our intellectual property right interests are not valid. Any claims against us, with or without merit, could be time consuming and costly to defend or litigate, divert our attention and resources, result in the loss of goodwill associated with our service marks or require us to make changes to our website or other of our technologies.

39


             Our products may become obsolete and unmarketable if we are unable to respond adequately to rapidly changing technology and customer demands.

            Our industry is characterized by rapid changes in technology and customer demands. As a result, our products may quickly become obsolete and unmarketable. Our future success will depend on our ability to adapt to technological advances, anticipate customer demands, develop new products and enhance our current products on a timely and cost-effective basis. Further, our products must remain competitive with those of other companies with substantially greater resources. We may experience technical or other difficulties that could delay or prevent the development, introduction or marketing of new products or enhanced versions of existing products. Also, we may not be able to adapt new or enhanced services to emerging industry standards, and our new products may not be favorably received.

             Unless we can establish broad market acceptance of our current products, our potential revenues may be significantly reduced.

            We expect that a substantial portion of our future revenue will be derived from the sale of our software products. We expect that these product offerings and their extensions and derivatives will account for a majority of our revenue for the foreseeable future. Broad market acceptance of our software products is, therefore, critical to our future success and our ability to continue to generate revenues. Failure to achieve broad market acceptance of our software products as a result of competition, technological change, or otherwise, would significantly harm our business. Our future financial performance will depend primarily on the continued market acceptance of our current software product offerings and on the development, introduction and market acceptance of any future enhancements. There can be no assurance that we will be successful in marketing our current product offerings or any new product offerings, applications or enhancements, and any failure to do so would significantly harm our business.

             Our use of open source software could impose limitations on our ability to commercialize our products.

            We incorporate open source software into our products. Although we closely monitor our use of open source software, the terms of many open source software licenses have not been interpreted by U.S. courts, and there is a risk that such licenses could be construed in a manner that could impose unanticipated conditions or restrictions on our ability to sell our products. In such event, we could be required to make our proprietary software generally available to third parties, including competitors, at no cost, to seek licenses from third parties to continue offering our products, to re-engineer our products or to discontinue the sale of our products in the event re-engineering cannot be accomplished on a timely basis or at all, any of which could adversely affect our revenues and operating expenses.

             We may not be able to obtain necessary licenses of third-party technology on acceptable terms, or at all, which could delay product sales and development and adversely impact product quality.

            We have incorporated third-party licensed technology into our current products. We anticipate that we are also likely to need to license additional technology from third-parties to develop new products or product enhancements in the future. Third-party licenses may not be available or continue to be available to us on commercially reasonable terms. The inability to retain any third-party licenses required in our current products or to obtain any new third-party licenses to develop new products and product enhancements could require us to obtain substitute technology of lower quality or performance standards or at greater cost, and delay or prevent us from making these products or enhancements, any of which could seriously harm the competitive position of our products.

             Our products must interoperate with many different networks, software applications and hardware products, and this interoperability will depend on the continued prevalence of open standards.

            Our products are designed to interoperate with our customers’ existing and planned networks, which have varied and complex specifications, utilize multiple protocol standards, software applications and products from numerous vendors and contain multiple products that have been added over time. As a result, we must attempt to ensure that our products interoperate effectively with these existing and planned networks. To meet these requirements, we have and must continue to undertake development and testing efforts that require significant capital and employee resources. We may not accomplish these development efforts quickly or cost-effectively, or at all. If our products do not interoperate effectively, installations could be delayed or orders for our products could be cancelled, which would harm our revenue, gross margins and our reputation, potentially resulting in the loss of existing and potential customers. The failure of our products to interoperate effectively with our customers’ networks may result in significant warranty, support and repair costs, divert the attention of our engineering personnel from our software development efforts and cause significant customer relations problems.

40


            Additionally, the interoperability of our products with multiple different networks is significantly dependent on the continued prevalence of standards for IP multimedia services, such as SIP or Session Initiation Protocol. Some of our existing and potential competitors are network equipment providers who could potentially benefit from the deployment of their own proprietary non-standards-based architectures. If resistance to open standards by network equipment providers becomes prevalent, it could make it more difficult for our products to interoperate with our customers’ networks, which would have a material adverse effect on our ability to sell our products to service providers.

             We are subject to the credit risk of our customers, which could have a material adverse effect on our financial condition, results of operations and liquidity.

            We are subject to the credit risk of our customers. Businesses that are good credit risks at the time of sale may become bad credit risks over time. In times of economic recession, the number of our customers who default on payments owed to us tends to increase. If we fail to adequately assess and monitor our credit risks, we could experience longer payment cycles, increased collection costs and higher bad debt expense.

             We are exposed to fluctuations in interest rates and exchange rates associated with foreign currencies.

            A majority of our revenue activities are transacted in U.S. dollars. However, we are exposed to foreign currency exchange rate risk inherent in conducting business globally in numerous currencies, of which the most significant to our operations for the three months ended October 31, 2018 is the Canadian dollar. We are primarily exposed to a fluctuating Canadian dollar as our operating expenses are primarily denominated in Canadian dollars while our revenues are primarily denominated in U.S. dollars. We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. Our company’s foreign currency risk management program includes foreign currency derivatives with cash flow hedge accounting designation that utilizes foreign currency forward contracts to hedge exposures to the variability in the U.S. dollar equivalent of anticipated non-U.S. dollar-denominated cash flows. These instruments generally have a maturity of less than one year. For these derivatives, our company reports the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss) in stockholders’ equity and reclassifies it into earnings in the same period in which the hedged transaction affects earnings, and within the same line item on the consolidated statements of operations as the impact of the hedged transaction. There can be no assurance that our hedging program will not result in a negative impact on our earnings and earnings per share. We did not enter into any forward contracts for hedging purposes during the three months ended October 31, 2018 (2017 - none).

             Tax matters, including changes in tax rates, disagreements with taxing authorities and imposition of new taxes could impact our results of operations and financial condition.

            We are subject to income taxes as well as non-income-based taxes, such as payroll, sales, use, value added, net worth, property, withholding and franchise taxes in both the U.S. and various foreign jurisdictions. From time to time, we are also subject to reviews, examinations and audits by taxing authorities with respect to such income and non-income-based taxes inside and outside of the U.S. When a taxing authority disagrees with our tax positions, we could face additional tax liabilities, including interest and penalties. Payment of such additional amounts upon final settlement or adjudication of any disputes could have a material impact on our results of operations and financial position.

            In addition, we are directly and indirectly affected by new tax legislation and regulation and the interpretation of tax laws and regulations worldwide. Changes in legislation, regulation or interpretation of existing laws and regulations in the U.S. and other jurisdictions where we are subject to taxation could increase our taxes and have an adverse effect on our operating results and financial condition.

41


             If a security breach or cyberattack of our IT networks and systems, or any of our products, occurs, our operations could be interrupted, our products and services may be perceived as vulnerable, and our brand and reputation could be damaged, which could reduce revenue, increase expenses, and expose us to legal claims or regulatory actions.

Cybersecurity refers to the combination of technologies, processes, and procedures established to protect information technology systems and data from unauthorized access, attack, or damage. We are subject to cybersecurity risks. Information cybersecurity risks have significantly increased in recent years and, while we have not experienced any material losses relating to cyber-attacks or other information security breaches, we could suffer such losses in the future. Our computer systems, software and networks may be vulnerable to unauthorized access, computer viruses or other malicious code and other events that could have a security impact. If one or more of such events occur, this potentially could jeopardize confidential and other information, including nonpublic personal information and sensitive business data, processed and stored in, and transmitted through, our computer systems and networks, or otherwise cause interruptions or malfunctions in our operations or the operations of our customers or counterparties. This could result in significant losses, reputational damage, litigation, regulatory fines or penalties, or otherwise adversely affect our business, financial condition or results of operations. Privacy and information security laws and regulation changes, and compliance with those changes, may result in cost increases due to system changes and the development of new administrative processes. In the future, we may be required to expend significant additional resources to modify our protective measures and to investigate and remediate vulnerabilities or other exposures arising from operational and security risks. In addition, we may be subject to litigation and financial losses that are not fully insured.

Risks Associated with our Common Stock

             Our directors control a substantial number of shares of our common stock, decreasing your influence on stockholder decisions.

            Based on the 5,943,082 shares of common stock that were issued and outstanding as of October 31, 2018, our directors owned approximately 50% of our outstanding common stock. As a result, our directors as a group could have a significant influence in delaying, deferring or preventing any potential change in control of our company; they will be able to strongly influence the actions of our board of directors even if they were to cease being directors of our company and can effectively control the outcome of actions brought to our stockholders for approval. Such a high level of ownership may adversely affect the exercise of your voting and other stockholder rights.

             We do not expect to pay dividends in the foreseeable future.

            We do not intend to declare dividends for the foreseeable future, as we anticipate that we will reinvest any future earnings in the development and growth of our business. Therefore, investors will not receive any funds unless they sell their common stock, and stockholders may be unable to sell their shares on favorable terms. We cannot assure you of a positive return on investment or that you will not lose the entire amount of your investment in our common stock.

             The exercise of all or any number of outstanding stock options or the issuance of other stock-based awards or any issuance of shares to raise funds may dilute your holding of shares of our common stock.

            If the holders of outstanding stock options and deferred share units exercise or settle all of their vested stock options and deferred share units as at October 31, 2018, then we would be required to issue an additional 1,059,762 shares of our common stock, which would represent approximately 15% of our issued and outstanding common stock after such issuances. The exercise of any or all outstanding stock options that are exercisable below market price will result in dilution to the interests of other holders of our common stock.

42


            We may in the future grant to certain or all of our directors, officers, insiders and key employees stock options to purchase the shares of our common stock, bonus shares and other stock based compensation as non-cash incentives to such persons. Subject to applicable stock exchange rules, if any, we may grant these stock options and other stock based compensation at exercise prices equal to or less than market prices, and we may grant them when the market for our securities is depressed. The issuance of any additional shares of common stock or securities convertible into common stock will cause our existing shareholders to experience dilution of their holding of our common stock.

            In addition, shareholders could suffer dilution in their net book value per share depending on the price at which such securities are sold. Such issuance may cause a reduction in the proportionate ownership and voting power of all other shareholders. The dilution may result in a decline in the price of our shares of common stock or a change in the control of our company.

             We may be considered a “penny stock.” Penny stock rules will limit the ability of our stockholders to sell their shares of common stock.

            The SEC has adopted regulations which generally define “penny stock” to be any equity security that has a market price (as defined) less than $5.00 per share or an exercise price of less than $5.00 per share, subject to certain exceptions. In addition, since our common stock commenced trading on the NASDAQ Capital Market below the $4.00 minimum bid price per share requirement, our common stock would be considered a penny stock if we fail to satisfy the net tangible assets and revenue tests in Rule 3a51-1 under the Securities Exchange Act of 1934. Our securities may be covered by the penny stock rules, which impose additional sales practice requirements on broker-dealers who sell to persons other than established customers and “accredited investors”. The term “accredited investor” refers generally to institutions with assets in excess of $5,000,000 or individuals with a net worth in excess of $1,000,000 or annual income exceeding $200,000 or $300,000 jointly with their spouse. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document in a form prepared by the SEC which provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction and monthly account statements showing the market value of each penny stock held in the customer's account. The bid and offer quotations, and the broker-dealer and salesperson compensation information, must be given to the customer orally or in writing prior to effecting the transaction and must be given to the customer in writing before or with the customer's confirmation.

            In addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from these rules, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser's written agreement to the transaction. These disclosure requirements may have the effect of reducing the level of trading activity in the secondary market for the stock that is subject to these penny stock rules. Consequently, these penny stock rules may affect the ability of broker-dealers to trade our securities. We believe that the penny stock rules discourage investor interest in and limit the marketability of our common stock.

             The Financial Industry Regulatory Authority, or FINRA, has adopted sales practice requirements, which may limit a stockholder's ability to buy and/or sell shares of our common stock.

            The FINRA has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer's financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low priced securities will not be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit your ability to buy and sell our stock and have an adverse effect on the market for its shares.

43


             Securities analysts may not publish favorable research or reports about our business or may publish no information which could cause our stock price or trading volume to decline.

            The trading market for our common stock will be influenced by the research and reports that industry or financial analysts publish about us and our business. We do not control these analyst reports. As a relatively small public company, we may be slow to attract research coverage and the analysts who publish information about our common stock will have had relatively little experience with our company, which could affect their ability to accurately forecast our results and make it more likely that we fail to meet their estimates. If any of the analysts who cover us issue an adverse opinion regarding our stock price, our stock price may decline. If one or more of these analysts cease coverage of our company or fail to regularly publish reports covering us, we could lose visibility in the market, which in turn could cause our stock price or trading volume to decline.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Recent Sales of Unregistered Securities

            None.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

  Issuer Purchases of Equity Securities  





Period



Total number
of shares
purchased


Average price
paid per share
(Canadian
dollars)

Total number of
shares purchased
as part of publicly
announced plans
or programs
Maximum
number of shares
that may yet be
purchased under
the plans or
programs (1)
8/1/2018 – 8/31/2018 284,278
9/1/2018 – 9/30/2018 284,278
10/1/2018 – 10/31/2018 284,278
Total 284,278

  (1)

Pursuant to a normal course issuer bid announced on March 27, 2018, which commenced on March 29, 2018 and expires on March 28, 2019 to purchase up to 284,278 shares of our common stock.

On March 27, 2018, we announced our intention to purchase, by way of a normal course issuer bid, for cancellation purposes, up to 284,278 shares of our common stock, representing approximately 10% of our then outstanding public float. We believe that our shares trade in a price range that does not adequately reflect their underlying value based on our business prospects.

Purchases will be made on the open market through the facilities of the TSX, NASDAQ Capital Market or such other stock exchange or quotation system upon which our shares are then listed or quoted, including other Canadian marketplaces, at market prices prevailing at the time of purchase and may take place over a 12-month period beginning on March 29, 2018 and expiring on March 28, 2019. We are permitted to make block purchases once per calendar week in accordance with the rules of the TSX. The daily purchase restriction is 1,199 shares, subject to certain prescribed exemptions. All shares purchased by our company under the normal course issuer bid will be returned to treasury and cancelled.

In connection with the normal course issuer bid, we renewed our automatic share purchase plan with National Bank Financial Inc., in order to facilitate purchases of our shares. Under the purchase plan, National Bank may purchase shares on our behalf at times when we would ordinarily not be permitted to purchase shares due to internal trading blackout periods, insider trading rules or otherwise. The purchase plan has been approved by the TSX and was implemented as of March 28, 2018. Purchases will be made by National Bank on the open market based upon the parameters prescribed by the TSX, applicable laws and the terms and conditions of the purchase plan.

44


To our knowledge, none of our directors, senior officers or other insiders (as defined in the TSX Company Manual) intends to sell any shares under the normal course issuer bid. However, sales by such persons through the facilities of the TSX may occur if the personal circumstances of any such person change or if any such person makes a decision unrelated to these normal course purchases. The benefits to any such person whose shares are purchased would be the same as the benefits available to all other holders whose shares are purchased.

Stockholders may obtain a copy of the notice submitted to the TSX with respect to the normal course issuer bid, without charge, by contacting our Chief Financial Officer.

Item 3. Defaults Upon Senior Securities.

            None.

Item 4. Mine Safety Disclosures.

            Not Applicable.

Item 5. Other Information.

            None.

Item 6. Exhibits.

Exhibits required by Item 601 of Regulation S-K

(3) Articles of Incorporation and By-laws
   
3.1

Articles of Incorporation (incorporated by reference from our Registration Statement on Form SB-2 filed on July 16, 2003)

   
3.2

Bylaws (incorporated by reference from our Registration Statement on Form SB-2 filed on July 16, 2003)

   
3.3

Amended Bylaws (incorporated by reference from our Registration Statement on Form SB-2/A filed on September 3, 2003)

   
3.4

Articles of Merger (incorporated by reference from our Current Report on Form 8-K filed on September 15, 2005)

   
3.5

Amended Bylaws (incorporated by reference from our Current Report on Form 8-K filed on April 28, 2006)

   
3.6

Amended Bylaws (incorporated by reference from our Current Report on Form 8-K filed on April 22, 2008)

   
3.7

Amended Bylaws (incorporated by reference from our Current Report on Form 8-K filed on July 2, 2012)

   
3.8

Certificate of Amendment to Articles of Incorporation (incorporated by reference from our Quarterly Report in the Form 10-Q filed on December 12, 2013)

 

 

(4)

Instruments defining the rights of security holders, including indentures

 

 

4.1*

Employee Share Purchase Plan

45



4.2* Amended 2010 Stock Option Plan
   
4.3

Deferred Share Unit Plan (incorporated by reference from our Quarterly Report on Form 10-Q filed on March 13, 2017)

   
(10)

Material Contracts

   
10.1

Employment Agreement between CounterPath Solutions, Inc. and David Karp dated September 11, 2006 (incorporated by reference from our Quarterly Report on Form 10-QSB filed on September 14, 2006)

   
10.2

Piggyback Registrations Rights Agreement among our company and various shareholders, dated as of August 2, 2007 (incorporated by reference from our Current Report on Form 8-K filed on August 8, 2007)

   
10.3

Amended Employment Agreement between Donovan Jones and CounterPath Solutions R&D Inc., a wholly owned subsidiary of CounterPath Solutions, Inc. dated September 13, 2007 (incorporated by reference from our Quarterly Report on Form 10-QSB filed on September 14, 2007)

   
10.4

Form of Subscription Agreement between our company and various investors in connection with the non-brokered private placement completed on September 4, 2015 (incorporated by reference from our Current Report on Form 8-K filed on September 8, 2015)

   
10.5

Form of Warrant Certificate issued to various investors in connection with the non-brokered private placement completed on September 4, 2015 (incorporated by reference from our Current Report on Form 8-K filed on September 8, 2015)

   
10.6

Amended Employment Agreement between Donovan Jones and CounterPath Corporation and its wholly owned subsidiary, CounterPath Technologies Inc., dated February 17, 2016 (incorporated by reference from our Quarterly Report on Form 10-Q filed on March 15, 2016)

   
10.7

Form of Subscription Agreement between our company and various investors in connection with the non-brokered private placement completed on December 15, 2016 (incorporated by reference from our Current Report on Form 8-K filed on December 19, 2016)

   

10.8

Form of Subscription Agreement between our company and various investors in connection with the non-brokered private placement completed on July 20, 2017 (incorporated by reference from our Current Report on Form 10-Q filed on September 14, 2017)

   
10.9

Form of Subscription Agreement between our company and various investors in connection with the non-brokered private placement completed on January 24, 2018 (incorporated by reference from our Current Report on Form 8-K filed on January 26, 2018)

   
10.10

Amended Employment Agreement between David Karp and CounterPath Corporation and its wholly owned subsidiary, CounterPath Technologies Inc., dated March 7, 2018 (incorporated by reference from our Quarterly Report on Form 10-Q filed on March 13, 2018)

   
10.11

Loan Agreement between Wesley Clover International Corporation, KMB Trac Two Holdings Ltd. and CounterPath Corporation dated October 10, 2018 (incorporated by reference from our Current Report on Form 8-K filed on October 12, 2018)

   
10.12* Separation Agreement between Donovan Jones and CounterPath Corporation and CounterPath Technologies Inc. dated September 17, 2018
   
(14)

Code of Ethics

   
14.1

Code of Business Conduct and Ethics and Compliance Program (incorporated by reference from our Quarterly Report on Form 10-QSB filed on September 15, 2008)

46



(21) Subsidiaries of CounterPath Corporation
   
  CounterPath Technologies Inc. (incorporated in the Province of British Columbia, Canada)
   
  BridgePort Networks, Inc. (incorporated in the state of Delaware)
   
(31) Section 302 Certifications
   
31.1 Section 302 Certification of David Karp (filed herewith).
   
(32) Section 906 Certifications
   
32.1 Section 906 Certification of David Karp (filed herewith).

47


SIGNATURES

            Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

COUNTERPATH CORPORATION

By: /s/ David Karp  
  David Karp  
  Interim Chief Executive Officer  
  Chief Financial Officer, Treasurer and Secretary  
  (Principal Executive Officer, Principal Financial Officer and  
  Principal Accounting Officer)  
     
Date: December 12, 2018  

48





 

 

COUNTERPATH CORPORATION

EMPLOYEE SHARE PURCHASE PLAN

 

 

 

 

 

 

Adopted October 1, 2008

Amended November 6, 2008, October 22, 2009, September 10, 2015, November 2, 2015 and October 22, 2018


COUNTERPATH CORPORATION

EMPLOYEE SHARE PURCHASE PLAN

 

Table of Contents

1. Purpose of the Plan 2
     
2. Definitions 3
     
3. Eligibility for Membership in the Plan 5
     
4. Contributions 6
     
5. Dividend and Interest Payments and Voting Rights 7
     
6. Purchase of Shares 8
     
7. Vesting of Contributions 8
     
8. Withdrawals, Transfers, Sales and Suspensions 9
     
9. Distribution on Retirement, Termination of Employment or Death 10
     
10. Distribution of Benefits on Termination of Membership 10
     
11. Amendment or Termination of Plan 11
     
12. Trustee 12
     
13. Administration 13
     
14. Market Fluctuation and Selling of Shares 13
     
15. Miscellaneous Provisions 13
     
Appendix A – Form of Election to Purchase Shares 16
   
Appendix B – Form of Instrument Changing Employee Contribution Level 17
   
Appendix C – Form of Withdrawal, Transfer or Sale of Shares 18
   
Appendix D – Form of Instrument Suspending Contributions 20
   
Appendix E – Form of Instrument Resuming Contributions 21
   
Appendix F – Form of Instrument Cancelling Participation 22

1.

PURPOSE OF THE PLAN

   
1.1

The Company hereby establishes a share purchase plan (the “Plan”) for the Employees of the Company and its Subsidiaries.

   
1.2

Subject to all required regulatory approvals, this Plan shall be effective as of and from October 1, 2008 (the “Commencement Date”) until the Expiry Date, unless earlier terminated as provided herein.

   
1.3

The purpose of this plan is to give employees of the Company access to another equity participation vehicle by way of an opportunity to purchase common shares of the Company through payroll deductions and encourage them to use their combined best efforts on behalf of the Company to improve its profits through increased sales, reduction of costs and increased efficiency.

2



2.

DEFINITIONS

   
2.1

In this Plan, the following terms shall have the meanings set forth below.


  (a)

“Account(s)” means one or more of a Cash Account, an RRSP Account, or a TFSA Account created by the Trustee for a Participant, in which the assets held by the Trustee for such Participant under the terms of this Plan are held and recorded.

     
  (b)

“Acquirer” means the successor to all or substantially all of the assets or capital shares of the Company, or any other successor of the business of the Company as determined by the Board of Directors, in either case pursuant to a Change of Control, and includes the affiliated entities of any such successor;

     
  (c)

“Basic Compensation” means the base salary received by an Employee in the applicable Pay Period but does not include, without limitation, overtime pay, commissions, bonus payments, or the value of other benefits or amounts contributed by the Company under this Plan.

     
  (d)

“Board of Directors” means the board of directors of the Company, or if the Board of Directors has delegated administration of the Plan to a compensation committee, then “Board of Directors” shall mean such compensation committee.

     
  (e)

“Business Day” means any day other than a Saturday, Sunday or statutory or civic holiday on which chartered banks in Vancouver, British Columbia are open for business.

     
  (f)

“Cash Account” means an account, which is not a registered retirement savings plan account, created by the Trustee for a Participant in which the assets subject to this Plan are held and recorded.

     
  (g)

“Cessation Date” means the date that the Participant ceases for any reason (other than death or Retirement, but otherwise including, without limitation, resignation, Disability, or termination of employment with or without cause), to render Service to the Company or a Subsidiary; provided, that, notwithstanding any other term or provision of this Plan, in the event of the termination of the Participant’s Service without cause, the Cessation Date shall be the date the Participant is given actual notice of termination by the Company or a Subsidiary, without reference to any period of notice of termination to which the Participant may be entitled at law or pursuant to any employment agreement, whether or not such termination has been effected in accordance with applicable law.

     
  (h)

“Change of Control” means (i) a merger, amalgamation, consolidation, reorganization or arrangement of the Company with or into another corporation (other than a merger, amalgamation, consolidation, reorganization or arrangement of the Company with one or more of its related entities (as defined in NI 45-106); (ii) a tender offer for all or substantially all of the outstanding common shares of the Company; (iii) the sale of all or substantially all of the assets of the Company; or (iv) any other acquisition of the business of the Company as determined by the Board of Directors.

     
  (i)

“Commencement Date” has the meaning set forth in Section 1.2 of this Plan.

     
  (j)

“Company” means CounterPath Corporation, and any successor company resulting from the amalgamation of the Company and any other company or other entity resulting from any other form of corporate reorganization thereof.

     
  (k)

“Disability” means the inability of the Participant to engage in substantial gainful activity by reason of a medically determinable physical or mental impairment (which state shall be determined by the Company on the basis of such medical evidence as the Company deems warranted in the circumstances).

3



  (l)

“Election to Purchase Shares” means an election, substantially in the form as set forth in Appendix A hereto, setting out the terms of an Employee’s election to participate in, and purchase Shares under, the Plan.

     
  (m)

“Employee” means a person (including a resident of the United States or outside of North America) under a permanent full-time or part-time contract of employment with the Company or a Subsidiary who participates in the Company’s or any of its Subsidiaries’ regular benefit plans (which fact shall be determined exclusively by the Board of Directors) including, without limitation, any such person who is also an officer or a director of the Company or a Subsidiary.

     
  (n)

“Expiry Date” means October 1, 2028.

     
  (o)

“Exchange” means the Toronto Stock Exchange in the case of shares purchased in Canada and the NASDAQ in the case of shares purchased in the United States or any other share exchange upon which the Shares are then listed and traded.

     
  (p)

“form” means any paper-based, web-based or any other electronic form as determined by the Company from time to time and includes the forms attached hereto which may be delivered, executed or otherwise completed in a method determined by the Company including the determination that such delivery, execution or completion be by way of any electronic or web- based means.

     
  (q)

“Insider” has the meaning set forth in the Securities Act and includes associates and affiliates (as such terms are defined by the Exchange) of the Insider.

     
  (r)

“Market Price” means the closing trading price of the Shares on the Exchange on such date in question, or, if Shares were not traded on such date on the Exchange, then on the preceding trading day during which a trade occurred.

     
  (s)

“Matching Assets” means all dividends and other assets allocated to a Participant’s Account on account of the Matching Shares.

     
  (t)

“Matching Shares” means Shares issued by the Company, or purchased by the Trustee on behalf of the Company, as contemplated by Section 4.2 of this Plan.

     
  (u)

“NI 45-106” means National Instrument 45-106 – Prospectus Exemptions, promulgated under the Securities Act, as such instrument may be amended from time to time, or any successor instrument thereto;

     
  (v)

“Participant” means any eligible Employee (as determined solely by the Board of Directors) who has elected to participate in the Plan, who has submitted an Election to Purchase Shares and who has not subsequently withdrawn from the Plan.

     
  (w)

“Participant Assets” means all dividends and other assets allocated to a Participant’s Account on account of the Participant Shares.

     
  (x)

“Participant Shares” means Shares purchased by the Trustee on behalf of the Participant with monies contributed by the Participant.

     
  (y)

“Pay Period” means the normal weekly, bi-weekly or monthly pay period as determined by the Company from time to time.

4



  (z)

“Payroll Administrator” means, initially, ADP and thereafter the Payroll Administrator selected by the Company, and the successor or successors thereto from time to time.

     
  (aa)

“Purchase Price” means, on any particular day with reference to Shares, the volume weighted average trading price of the Shares on the Exchange for the five trading days immediately preceding the end of the month in question as determined by the Company.

     
  (bb)

“Retirement” means retirement at age sixty-five (65) or older.

     
  (cc)

“RRSP Account” means a registered retirement savings plan account.

     
  (dd)

“Securities Act” means the Securities Act (British Columbia), as the same may be amended from time to time.

     
  (ee)

“Service” means continuous service to the Company or any of its Subsidiaries as an Employee.

     
  (ff)

“Share Compensation Arrangement” means a plan or program established or maintained by the Company providing for the acquisition of securities of the Company as compensation or as an incentive or benefit for services provided to the Company.

     
  (gg)

“Shares” means the common shares in the capital of the Company as presently constituted; provided that upon any subdivision, consolidation or reorganization of such shares or other change in the corporate structure or share capital of the Company, “Shares” shall mean such ordinary shares as are subdivided, consolidated, reorganized or changed, with such adjustment in the number thereof as may be thereby deemed appropriate by the Company.

     
  (hh)

“Subsidiary” means a corporation (located in Canada, the United States or outside of North America) or other entity which is controlled by the Company. For the purposes of this definition, the Company controls a body corporate or other entity if:


  (i)

in the case of a body corporate:

       
  A.

securities of the body corporate to which are attached more than 50% of the votes that may be cast to elect directors of the body corporate are held, other than by way of security only, by or for the benefit of the Company, and

       
  B.

the votes attached to those securities are sufficient, if exercised, to elect a majority of the directors of the body corporate; and

       
  (ii)

in the case of an entity other than a body corporate, more than 50% of the voting or equity interests of such entity are controlled, directly or indirectly, by or for the benefit of the Company.


  (ii)

“TFSA Account” means a tax-free savings account.

     
  (jj)

“Trustee” means the agent or agents of the Plan appointed by the Company in accordance with Section 12.1 of this Plan, and the successor or successors thereto from time to time.


3.

ELIGIBILITY FOR MEMBERSHIP IN THE PLAN

   
3.1

The Plan is open to all eligible Employees (as determined solely by the Board of Directors) at any time after the Employee has completed his/her probationary employment period with the Company subject to the rules set forth below. Participation in the Plan is entirely voluntary.

5



  (a)

Enrolment . An Employee shall become a Participant by duly executing and delivering to the Company an Election to Purchase Shares; provided that, the Participant’s participation in the Plan shall only be effective on the first day of the first Pay Period following the date that is thirty (30) days after such Election to Purchase Shares is received by the Company. The Election to Purchase Shares authorizes the Company or a Subsidiary, as applicable, to make regular payroll deductions for contributions to the Plan in respect of Participants.

     
  (b)

Termination of Employment . Participation in the Plan shall cease on the Cessation Date (in the event that the Participant’s Service is terminated for any reason other than death or Retirement) or the death or Retirement of the Employee, whichever is first to occur.

     
  (c)

Re-Employment . Except in cases of leave of absence approved in writing by the Company or a Subsidiary, a former Employee who is subsequently re-employed by the Company or a Subsidiary shall be considered a new Employee for the purposes of the Plan.

     
  (d)

Leave of Absence . A Participant who is on leave of absence or is absent due to illness or Disability shall not be permitted to make any contribution for that period of absence; during that period of absence, such Participant shall be deemed to remain in the employ of the Company or a Subsidiary for all other purposes of the Plan.

     
  (e)

Election to Purchase Shares . Each Employee who requests information about the Plan shall have delivered to him or her a copy of the Plan together with an Election to Purchase Shares to become a Participant. Execution of an Election to Purchase Shares by the Employee and admittance by the Company of the Employee as a Participant shall be deemed to be an acceptance by the Employee of the terms and forms of the Plan without further action or other formality.

     
  (f)

Plan Shares . The Participant Shares that may be purchased by the Trustee from the Company on behalf of the Participants, and, the Matching Shares that may be issued by the Company to the Trustee on behalf of the Participants, in accordance with the terms of the Plan at any time, shall be authorized and unissued Shares of the Company in an amount up to but not exceeding an aggregate of 220,000 Shares, and such number of Shares shall be set aside for the purposes of the Plan. The Company reserves the right to allocate Shares to Participants on a pro-rata basis should the number of Shares to be purchased or issued under the Plan exceed 220,000 Shares.

     
  (g)

Price of Shares . The price at which Participant Shares purchased from the Company and Matching Shares issued by the Company in accordance with the terms hereof shall be the Purchase Price or the price at which purchased on the open market.


4.

CONTRIBUTIONS

   
4.1

Employee Contributions .


  (a)

Each Participant shall contribute through payroll deductions to the Plan in each Pay Period, at the Participant’s option as designated by the Participant, an amount equal to or between the following minimum and maximum amounts (in whole percentages only):

       
  (i)

a minimum of one percent (1%) of the Participant’s Basic Compensation; and

       
  (ii)

a maximum of six percent (6%) of the Participant’s Basic Compensation.


  (b)

If a Participant is resident in Canada, a Participant shall be permitted to contribute Participant Shares and Matching Shares to such Participant’s RRSP Account or TFSA Account. The Participant is solely responsible for ensuring that contributions made to the Plan do not exceed the maximum dollar limit under the Income Tax Act (Canada) for contributions to registered retirement savings plans. For greater certainty, neither the Company nor any Subsidiary nor the Trustee shall be responsible for any taxes or penalties that result from a breach of the maximum dollar limit under the Income Tax Act (Canada).

6



  (c)

The Company or a Subsidiary, as agent of the Participant, shall make (or direct the Payroll Administrator to make) the payroll deductions required by the terms of the Plan and pay (or direct the Payroll Administrator to pay) the Participant’s contribution to the Trustee in accordance with Section 4.1(e) below, and the Company, its Subsidiaries and each Payroll Administrator is authorized by the Participant to do so by such Participant’s execution of an Election to Purchase Shares.

     
  (d)

The Participant may change his or her contribution level twice in any 12 month period by filing a form with the Company, substantially in the form as set forth in Appendix B hereto (or other applicable form as provided by the Trustee), indicating the change to the Company, at least 30 days prior to the applicable effective date of such change.

     
  (e)

On the last day Business Day of each month, the Company shall (or shall direct the Payroll Administrator to) forward all monies deducted from Participants by means of payroll deductions (as provided in Section 4.1 hereof), to the Trustee who shall hold such monies for the benefit of each of the Participants (subject to the provisions of Section 7 hereof). The Trustee shall maintain a separate Account or Accounts for each Participant to which shall be credited all of such Participant’s contributions.


4.2

Corporate Contribution . On the last Business Day of each month, the Company will either (1) forward monies equal to fifty (50%) of the Participant’s contributions such that the Trustee may acquire Matching Shares equal to fifty (50%) of the aggregate number of Participant Shares purchased by the Trustee on behalf of the Participants for such month as set out in Section 6 herein, or (2) issue to the Trustee that number of Matching Shares equal to fifty (50%) of the aggregate number of Participant Shares purchased by the Trustee on behalf of the Participants for such month. All Matching Shares so issued or purchased shall be immediately released and transferred to the Participant’s Cash Account, RRSP Account, or TFSA Account, as directed by the Participant, for the benefit of the Participant.

   
4.3

Tax Treatment of Contributions . The tax ramifications for Participants participating in the Plan will depend on a number of factors, including whether or not a Participant elects to purchase Shares pursuant to the Plan in an RRSP, TFSA, 401K, or other Account. Participants should note that income tax laws are subject to change and such changes may affect the tax treatment of the Plan and the Participant’s individual tax treatment. Participants should consult their tax advisors to determine their individual tax treatment in connection with their participation in the Plan. The Corporation will withhold appropriate income taxes and other required withholdings on the basis of each Participant’s actual salary.

   
4.4

Costs and Expenses . The Company or its Subsidiaries shall pay all administration expenses in connection with the operation of the Plan, including, without limitation, all commissions for purchases of Shares. Commissions, taxes and all governmental or other charges in connection with sales, as well as all charges for or associated with any transfers, withdrawals or personal administrative requests, are payable by the Participant who orders the transaction for his or her Account.

   
5.

DIVIDEND AND INTEREST PAYMENTS AND VOTING RIGHTS

   
5.1

Dividends and Interest . Dividends on Shares will be allocated to the appropriate Accounts by the Trustee upon receipt of such amounts by the Trustee. Cash dividends are reinvested in the Shares as soon as possible subject to available trading volumes. Contributions are withheld by the Trustee without interest or benefit accruing to the Participant.

   
5.2

Reports and Voting . The Trustee will deliver to each Participant, as promptly as practicable, by mail or otherwise, all notices of meetings, proxy statements and other material distributed by the Company to its shareholders. There is no charge to the Participants for the Trustee’s retention of share certificates, or in connection with the notices, proxies or other such material. The full Shares in each Participant’s Account shall be voted in accordance with such Participant’s signed proxy instructions duly delivered. In the absence of such instructions, the Shares will not be voted. In the alternative, the Trustee may sign a proxy granting a Participant a right to vote, on behalf of the Trustee, the Shares held by the Trustee in the Participant’s Account.

7



6.

PURCHASE OF SHARES

   
6.1

Purchase of Participant Shares . On the last Business Day of each month, the Trustee shall pool all contributions received from the Participants and the Company during such month and shall forthwith, at the written direction of the Company, either:


  (a)

subscribe for and purchase from the Company such number of Participant Shares, at the Purchase Price, that those contributions can buy; or

     
  (b)

purchase through a stock broker on the open market through the facilities of the Exchange such number of Participant Shares, at the price on the open market, that those contributions can buy; provided that if such purchase cannot be completed within fifteen (15) days, then the Trustee shall purchase the Participant Shares from the Company as provided for in Section 6.1(a) hereof.


Such direction by the Company to the Trustee shall be and remain effective until the Company provides a subsequent direction to the Trustee. The Company shall pay all brokers’ commissions, or similar fees, incurred in connection with any purchases of Shares by the Trustee. The Company shall have no control over the timing or price of Participant Shares purchased on the open market in accordance with Section 6.1(b).

   
6.2

Issuance of Matching Shares . On the last Business Day of each month, if applicable, the Company shall issue to the Trustee such number of Matching Shares equal to fifty (50%) of the aggregate number of Participant Shares purchased by the Trustee pursuant to Section 6.1 above.

   
6.3

Share Certificates . Certificates or an applicable book entry representing the Shares purchased, issued or otherwise received by the Trustee pursuant to the Plan shall be registered in the name of the Trustee and shall be held by the Trustee for the benefit of the Company and the Participants in accordance with the terms of this Plan.

   
6.4

Crediting of Shares to Accounts . The monthly aggregate number of Shares purchased by the Trustee with the contributions made by the Participants shall be allocated by the Trustee to each Account of the Participants, in proportion to the contributions made by or on behalf of the Participant. If applicable, the monthly aggregate number of Matching Shares issued by the Company to the Trustee shall be allocated by the Trustee to each Account of the Participants, as being attributable to the Participant in respect to whom such Matching Shares were issued. Allocations of fractional shares shall be permitted.

   

Stock dividends, stock splits, or both, as applicable, in respect of Shares that are held in the Participant’s Account will be credited to the Account without charge. Distributions of other securities (except pursuant to a merger, consolidation or other reorganization of the Company) and rights to subscribe may be sold and the proceeds will be handled in the same manner as a cash dividend.

   
7.

VESTING OF CONTRIBUTIONS

   
7.1

Participant Shares . All Participant Shares, Participant Assets, Matching Shares and Matching Assets shall be fully vested immediately upon receipt of such Shares or assets, as applicable, by the Trustee.

8



7.2

Rights of Matching Shares The Matching Shares shall have the same rights (including, without limitation, voting, dividend or liquidation rights) as the Company’s common shares and shall be eligible for inclusion in an RRSP or TFSA.

   
7.3

Termination of Service . On the termination of the Participant’s Service for any reason: (i) the Participant Shares and Participant Assets, and (ii) any and all Matching Shares and Matching Assets, shall be dealt with as provided in Section 9.

   
8.

WITHDRAWALS, TRANSFERS, SALES AND SUSPENSIONS

   
8.1

Withdrawal, Transfer or Sale . At the end of any month and subject to prior express notice to the Company and the Trustee (such notice being in a form as determined by the Company and the Trustee), a Participant may withdraw, transfer or sell up to 100% of the Shares in such Participant’s Account; provided that during the previous twelve (12) calendar months such Participant has not made more than one other withdrawal, transfer or sale from the Plan. After obtaining approval from the Company for such withdrawal, transfer or sale, the Trustee shall satisfy such withdrawal, transfer or sale request by: (i) in the case of a withdrawal or transfer request, delivering all Shares (other than fractional Shares) requested to be withdrawn or transferred by the Participant, held in the Participant’s Account, to the Participant or such third party as designated by the Participant, and (ii) in the case of a sale, by selling all Shares (other than fractional Shares) requested to be sold by the Participant, held in the Participant’s Account, and distribute the cash proceeds to the Participant, less any commissions or fees, as applicable, provided that any such sale of Shares is in accordance with Section 14.2. No withdrawal or transfer of any cash amount in a Participant’s Account shall be permitted as part of a withdrawal or transfer of Shares from such Account pursuant to the provisions of this Section 8.1. The value of any fractional Shares requested to be withdrawn, transferred or sold shall be converted to cash by the Trustee and allocated to such Participant’s Account for payment to such Participant.

   

If a Participant makes two withdrawals, transfers or sales from the Plan in any twelve (12) month period pursuant to the provisions of Section 8.1 hereof, then such Participant shall be prohibited from making further contributions to, or withdrawals, transfers or sales from, the Plan (other than a withdrawal, transfer or sale of the remaining assets in such Participant’s Account upon termination of such Participant’s membership in the Plan as set forth in Section 10 hereof) until the first Business Day of the month following the first anniversary of such second withdrawal, transfer or sale. The form to be used by a Participant for the withdrawal, transfer or sale of Shares shall be substantially in the form as set forth in Appendix C hereto, which shall indicate, among other things, the number of Shares such Participant wishes to withdraw, transfer or sell and, in the case of a withdrawal or transfer, the particulars relating to the registration of the Shares that are to be delivered, if any.

   

Notwithstanding the foregoing, the Company, in its sole discretion, has the right to vary or amend the number of withdrawals, transfers or sales permitted by any Participant in accordance with this Section 8.1 based on extenuating circumstances or compassionate grounds. Such variance or amendment shall only apply to the Participant in question.

   
8.2

Suspension of Contributions . A Participant may elect at any time to suspend contributions to the Plan by giving at least thirty (30) days prior express written notice to the Company to that effect. During such period of suspension, the rights and obligations of such Participant, the Company and its Subsidiaries, and the Trustee shall remain in full force and effect. A Participant who has suspended contributions under this Section 8.2 may resume contributions to the Plan on a subsequent date by express written notice to the Company to that effect at least thirty (30) days prior to such date. The form to be used by a Participant for such a suspension shall be substantially in the form as set forth in Appendix D hereto. The form to be used by a Participant to resume contributions to the Plan shall be substantially in the form as set forth in Appendix E hereto.

9



9.

DISTRIBUTION ON RETIREMENT, TERMINATION OF EMPLOYMENT OR DEATH

   
9.1

Termination of Employment or Retirement of Participant . A Participant whose Service is terminated for any reason other than death, or a Participant who retires, must withdraw or otherwise transfer all of the Participant Shares, Participant Assets, Matching Shares and Matching Assets in the Participant’s Account within ninety (90) days of such termination of Service (for greater certainty, the number of Matching Shares to be released to the Participant under this Section 9.1 shall be determined as of the date the actual notice of termination of Service is given by the Corporation to the Participant without reference to any “notice period” or “severance period” or any other period after the date that actual notice of termination of Service is given) or retirement. In the absence of specific instructions as to the method of distribution or transfer within the said ninety (90) day period, Participant shall be deemed to have elected to request that:


  (a)

such Shares in the non-registered component of his or her Cash Account be transferred to an account in his or her name administered by the Trustee (ongoing administration costs being borne by the Participant); and

     
  (b)

if the Participant’s Shares are held in his or her RRSP Account, such Shares be transferred to a registered retirement savings plan of the former Participant under a group plan trusteed by the Trustee (ongoing RRSP administration costs being borne by the Participant); and

     
  (c)

if the Participant’s Shares are held in his or her TFSA Account, request such Shares and be transferred to a TFSA of the former Participant under a group plan trusteed by the Trustee (ongoing TFSA administration costs being borne by the Participant).


9.2

Death of Participant . Following the death of a Participant, the Shares and other assets in such Participant’s Account will be distributed by the Trustee to such Participant’s estate or Account beneficiary, if any. The distribution shall be made by the Trustee in accordance with the written instructions of the legal representative of the Participant’s estate (provided that the Trustee has been provided with all relevant supporting documentation that it customarily requires) or by the Account beneficiary by:


  (a)

the delivery of all Shares (other than any fractional Shares) and any cash held in the Participant’s Account;

     
  (b)

the distribution of cash realized from the sale of such Shares by the Trustee;

     
  (c)

a transfer to another registered retirement savings plan, if permitted by law; or

     
  (d)

a combination thereof.


The value of any fractional Shares shall be distributed in cash in an amount equal to the fraction multiplied by the Market Price on the Business Day prior to the date of payment. If the legal representative of the Participant’s estate or Account beneficiary fails to make an election within ninety (90) days of the Participant’s death, then the Trustee shall make delivery in accordance with the provisions set forth in Section 9.2(a) above.

   
9.3

Notifications to Trustee. The Company shall notify the Trustee in writing upon the Retirement, termination of employment or death of a Participant.

   
10.

DISTRIBUTION OF BENEFITS ON TERMINATION OF MEMBERSHIP

   
10.1

Cancellation of Participation . A Participant may cancel his or her Election to Purchase Shares at any time by express notice of cancellation delivered to and receipted for by the Company and the Trustee (such notice being in a form as determined by the Company and the Trustee). Upon receipt of such notice of cancellation, the Trustee shall return to the Participant the appropriate portion of the Participant’s Account in the manner set out in Section 9.1 hereof. Payment thereof shall constitute a discharge of the Company’s and its Subsidiaries’ obligations to the Participant under the Plan. If a Participant cancels his or her Election to Purchase Shares under the Plan, then the Participant shall not be entitled to rejoin or otherwise participate in such Plan until the first anniversary of such cancellation. The form to be used by a Participant to cancel his or her Election to Purchase Shares shall be substantially in the form as set forth in Appendix F hereto.

10



11.

AMENDMENT OR TERMINATION OF PLAN

   
11.1

Amendment or Termination . The Company reserves the right to discontinue use of payroll deductions at any time such action is deemed advisable, in its sole discretion. The Plan may be amended, altered or discontinued by the Company at any time, subject to obtaining: (i) any necessary approval of any applicable regulatory authority including, without limitation, the Exchange if the Shares are listed on the Exchange or any other stock exchange or market on which the Shares are then listed or admitted to trading; and (ii) if required by the rules of the Exchange if the Shares are listed on the Exchange, the approval of the shareholders of the Company in accordance with the rules, regulations and policies of the Exchange at a duly constituted meeting of shareholders (“Shareholder Approval”). Notwithstanding the foregoing, the following amendments to the Plan may be made by the Board without Shareholder Approval:


  (a)

amendments of a technical, clerical or “housekeeping” nature, or to clarify any provision of the Plan, including without limiting the generality of the foregoing, any amendment for the purpose of curing any ambiguity, error or omission in the Plan or to correct or supplement any provision of the Plan that is inconsistent with any other provision of the Plan;

     
  (b)

suspension or termination of the Plan;

     
  (c)

amendments to respond to changes in legislation, regulations, instruments (including NI 45- 106), stock exchange rules (including the rules, regulations and policies of the Exchange) or accounting or auditing requirements;

     
  (d)

amendments respecting administration of the Plan;

     
  (e)

any amendment to the definition of “Employee”;

     
  (f)

any amendment to the definition of “Subsidiary”;

     
  (g)

changes to the vesting provisions for any outstanding Matching Shares;

     
  (h)

amendments to the Participant contribution provisions of the Plan;

     
  (i)

amendments to the withdrawal and suspension provisions of the Plan;

     
  (j)

amendments to the number or percentage of Matching Shares contributed by the Company;

     
  (k)

amendments to the termination provisions of the Plan;

     
  (l)

adjustments to reflect stock dividends, stock splits, reverse stock splits, share combinations or other alterations of the capital stock of the Company; and

     
  (m)

any other amendment, whether fundamental or otherwise, not requiring shareholder approval under applicable law (including, without limitation, the rules, regulations and policies of the Exchange).

Shareholder Approval will be required for the following types of amendments:

11



  (i)

amendments to the number of Shares issuable under the Plan, including an increase to the fixed maximum number of Shares or a change from a fixed maximum number of Shares to a fixed maximum percentage; and

     
  (ii)

amendments required to be approved by shareholders under applicable law (including, without limitation, the rules, regulations and policies of the Exchange).


In the event of any conflict between subsections (a) to (m) and subsections (i) to (ii), above, the latter shall prevail to the extent of any conflict.

   

In the event of any amendment or termination of the Plan in accordance with this Section 11, such amendment or termination will not result in the forfeiture of any funds deducted from the Basic Compensation of any Participant, or any dividends or other distributions in respect of the Participant Shares, effective before the effective date of amendment or termination of the Plan. In the event of any termination, each Participant shall be entitled to 100% of the Participant Shares, Participant Assets, Matching Shares and Matching Assets in the Participant’s Account as of the date of such termination, which shall be distributed to each Participant within ninety (90) days following termination of the Plan.

   
12.

TRUSTEE

   
12.1

The Company shall designate the Trustee to open and maintain Accounts for the benefit of the Participants and to arrange for purchases of the Participant Shares and receipt of the Matching Shares. The Company may, in its discretion, substitute another corporation as Trustee under the Plan and the Trustee may terminate its services, provided such substitution or termination, as the case may be, shall be on ninety (90) days notice given by the party effecting the action.

   
12.2

The Trustee is authorized and directed by the Company and the Participants to purchase Participant Shares and receive Matching Shares, provided that the Trustee has been provided with the contributions and necessary payroll information. The Trustee agrees to make such purchases of Participant Shares as soon as such contributions are received, and if such Participant Shares are being purchased on the open market subject to the trading volume of the Shares. Participant Shares shall be allocated absolutely, and Matching Shares shall be allocated subject to the terms and provisions of the Plan (including without limitation Section 7.2 hereof) by the Trustee to such Participant’s Account.

   
12.3

The Trustee shall maintain an Account for each Participant showing a record of the assets held in each such Participant’s Account under the Plan, and the interest accrued thereon, if any. The Trustee shall furnish to the Participants a summary by way of a password-protected web-page containing the following information:


  (a)

the total amount of the contributions made by such Participant; and

     
  (b)

the number of Shares in such Participant’s Account.


Each such statement shall be deemed to have been accepted by the Participant as correct unless written notice to the contrary shall have been received by the Trustee within three (3) months of the date of such statement.

   
12.4

The Trustee shall be protected in acting and relying upon any written notice, certificate, confirmation, request, waiver, consent, receipt, statutory declaration or other paper or document (collectively referred to as the “Documents”) furnished to it and signed by any person required to or entitled to execute and deliver to the Trustee any such Documents in connection with any action or omission of the Trustee hereunder, not only as to its due execution and the validity and effectiveness of the Documents’ provisions, but also as to the truth and accuracy of any information therein contained, which the Trustee in good faith believes to be genuine.

12



12.5

No amendment, change or modification to the Plan shall be made which will, without the Trustee’s consent, alter the duties of the Trustee under the Plan.

   
13.

ADMINISTRATION

   
13.1

The Trustee shall act on behalf of the Company and its Subsidiaries in the day-to-day administration of the Plan.

   
13.2

Subject to the provisions of the Plan, the Company shall be authorized to interpret the Plan and to establish, amend and rescind any rules and regulations relating to the Plan and to make all other determinations necessary or advisable for the administration of the Plan. The Company may correct any defect, supply any omission and reconcile any inconsistency in the Plan and, to the extent it shall be deemed desirable by the Company, to carry it into effect. The determinations of the Company in the administration of the Plan, as described herein, shall be final and conclusive. The Company shall provide the Trustee with written notice of any amendments or changes to the Plan as described herein.

   
14.

MARKET FLUCTUATION AND SELLING OF SHARES

   
14.1

THERE IS NO GUARANTEE UNDER THE PLAN AGAINST LOSS OF VALUE OF THE SHARES. IN SEEKING THE BENEFITS OF PARTICIPATION IN THE PLAN, AN EMPLOYEE MUST ACCEPT THE RISK OF A DECLINE IN THE MARKET PRICE OF THE SHARES AND THE TOTAL LOSS OF HIS OR HER INVESTMENT IN THE SHARES. Neither the Company nor its Subsidiaries nor the Trustee will bear any responsibility for any loss that may occur as a result of such market fluctuation or otherwise. Neither the Company nor its Subsidiaries nor the Trustee makes any representation or warranty that the Shares are suitable investments for any particular eligible Employee. Subject to Section 6, any purchase or sale of the Shares or any other security by the Trustee provided for in this Plan may be at such price or prices and at such time or times for the purchase or sale of such Shares or securities, as are readily available on the Exchange. Subject to Section 6, neither the Trustee nor the Company nor its Subsidiaries shall be liable for the failure to purchase or sell the Shares or any other securities at any particular price, time or at all.

   
14.2

Issuance and Selling of Shares . No Shares issued to the Participant, or on behalf of the Participant, may be sold by the Participant, or on behalf of the Participant, unless such sale is in accordance with all applicable securities laws and the Company’s insider trading policy in effect from time to time. Accordingly, the Trustee shall obtain the approval of the Company for each sale by or on behalf of a Participant to ensure compliance with all applicable securities laws and the Company’s insider trading policy.

   
15.

MISCELLANEOUS PROVISIONS

   
15.1

The fiscal year of the Plan shall coincide with the Company’s fiscal year end.

   
15.2

Subject to Section 12.5, the Company reserves the right, at any time, to make rules regarding the interpretation, implementation and organization of the Plan, to prescribe, modify, amend or rescind the provisions of this Plan or to suspend this Plan; provided that no prescription, modification, amendment, rescission or suspension shall deprive a Participant of benefits vested in the Participant under the Plan or divert the use of the funds in the Accounts for purposes other than the exclusive benefit of the Participants.

   
15.3

Participants shall provide to the Company, its Subsidiaries and the Trustee any information that might be required of them in the administration of this Plan.

   
15.4

Neither this Plan nor any Trustee agreement entered into between the Company and the Trustee pursuant to this Plan shall give any Employee the right to be employed, or to continue to be employed, by the Company or any of its Subsidiaries.

13



15.5

No right or interest of any Participant in or under this Plan shall be subject to assignment, sale, transfer, pledge, encumbrance or charge, in whole or in part, either directly or by operation of law or otherwise in any manner otherwise than by death or mental incompetency, and shall be exercisable, during the Participant’s lifetime, only by the Participant. No attempted assignment, sale, transfer, pledge, encumbrance or charge thereof shall be effective and any attempt to do so shall be void. Any attempt to violate the provisions of this Section 15.5 shall be deemed a decision by the Participant to terminate participation in this Plan whereupon all of the Employee’s contributions credited to a violating Participant’s Account shall be immediately refunded to the Participant and the Participant shall no longer be considered a participant in the Plan. The Company shall notify the Trustee in writing of the need for such a refund.

   
15.6

No Participant or any other person shall have any right in or to any part of the corpus or income of the Accounts of the Plan, or any part of the assets thereof (including, without limitation, the assignment of any part of the Plan as a pledge or collateral for any loan or debt), except as and when and to the extent expressly provided by the Plan.

   
15.7

Participation in the Plan will not give any Participant any right or claim to any payment except as such payment is provided for under the provisions of the Plan and only to the extent that assets are available in the hands of the Trustee for the making of such payment and to the extent provided for in the Plan.

   
15.8

Any act or matter to be taken or decided by the Company under the Plan may be taken by or decided by the Board of Directors or the Company unless otherwise expressly set forth in this Plan.

   
15.9

The laws of the Province of British Columbia shall apply to this Plan, any amendments thereto, and the administration thereof, and all rights and obligations thereunder shall be determined in accordance with such laws and according to such Province.

   
15.10

Any purchase, sale or offering of Shares under the Plan shall be made on the express condition that an application to purchase Shares may not be made, nor may the purchase of any Shares thereunder be effected, under circumstances which would constitute a violation of any applicable securities or other law or regulation or any listing requirement, by-law or regulation of the Exchange or any other stock exchange on which the Shares are listed. The operation of the Plan may be suspended at any time, in the discretion of the Company, if necessary to ensure compliance with any applicable securities or other law or regulation or any listing requirement, by-law or regulation of the Exchange or any other stock exchange on which the Shares are listed or proposed to be listed. The Shares under the Plan may not be offered, sold, transferred, pledged hypothecated or otherwise assigned in the United States or any other jurisdiction unless pursuant to an available exemption under applicable securities laws. The Shares under the Plan have not been registered under the United States Securities Act of 1933, as amended, nor qualified under or pursuant to the securities or “Blue Sky” laws of any state. The Company’s obligation to issue and deliver Shares is subject to the availability, on terms and conditions reasonably satisfactory to the Company, of an exemption from prospectus and registration requirements in respect of the issuance, sale and delivery of such Shares under applicable securities and “Blue Sky” laws.

   
15.11

The Plan is effective beginning on the Commencement Date and will terminate on the Expiry Date.

   
15.12

Nothing contained in this Plan shall restrict or limit or be deemed to restrict or limit the rights or power of the Board of Directors in connection with any allotment and issuance of any securities of the Company.

14



15.13

Any word contained herein importing gender shall include the masculine and feminine and neuter. All references in this Plan to the words “herein”, “hereby”, “hereto”, “hereof”, and words of similar import refer to this Plan as a whole and not to any particular Section, schedule or appendix unless otherwise stated or the context otherwise requires.

ADOPTED as of October 1, 2008, as amended November 6, 2008, October 22, 2009, September 10, 2015, November 2, 2015 and October 22, 2018.

  COUNTERPATH CORPORATION

By:
             Name: David Karp
             Title: Interim Chief Executive Officer

15


Appendix A – Form of Election to Purchase Shares
Employee Share Purchase Plan
effective __________________, 2008

To: COUNTERPATH CORPORATION (the “Company”)
  Attention: Trustee, Employee Share Purchase Plan

            The undersigned employee acknowledges that he/she has been advised by the Company of the Company’s employee share purchase plan (the “Plan”) that the undersigned is eligible to participate in the Plan and that the undersigned has received a copy of the Plan and has read and understands the terms of the Plan.

            The undersigned irrevocably accepts the terms, conditions and forms of the Plan and hereby elects to participate in the Plan and hereby directs and authorizes the Company to deduct from the undersigned’s salary, by way of payroll deduction on each Pay Period, the amount (the “Employee Contribution”) of _____ % of the undersigned’s Participant’s Basic Compensation (minimum of 1% of the undersigned’s Participant’s Basic Compensation, maximum 6% of the undersigned’s Participant’s Basic Compensation, in whole percentages only). The Employee Contribution shall be used by the Trustee to purchase common shares (“Shares”) in the capital of the Company in accordance with the terms and subject to the conditions of the Plan.

            The undersigned hereby authorizes and directs the Trustee to purchase Shares on behalf of the undersigned in accordance with the terms of the Plan, and directs that the Shares be allocated by the Trustee to the Participant’s Account. In consideration of the Company establishing the Plan, the undersigned hereby irrevocably directs and authorizes the Trustee to carry out and perform the trusts created by the Plan and to hold the Shares purchased by the Trustee on behalf of the undersigned in accordance with the terms of the Plan and all of the rights, privileges and benefits conferred by the Plan for the benefit of the undersigned, on the terms and subject to the conditions contained in the Plan.

            In case of the undersigned’s death, the undersigned hereby designates that all assets then contained in the undersigned’s Account shall be distributed to ______________________ as my beneficiary for such assets. The name of the trustee, if any, in the event such beneficiary is a minor child is _______________________.

            Whenever used herein, any words or terms not otherwise defined in this Election to Purchase Shares, but defined in the Plan, shall have the meanings ascribed thereto in the Plan.

DATED as of the ______ day of ______________, 20_____.

     
(Witness)   (Signature of Employee)
     
     
     
    (Please Print Name)
     
     
     
    (Please Print Address)

16


Appendix B – Form of Instrument Changing Employee Contribution Level
Employee Share Purchase Plan
effective __________________, 2008

To: COUNTERPATH CORPORATION (the “Company”)
  Attention: Trustee, Employee Share Purchase Plan

            The undersigned employee hereby gives notice to, and directs, the Company to change the undersigned’s contribution to the Company’s employee share purchase plan (the “Plan”) to _______% of the undersigned’s Participant’s Basic Compensation (minimum of 1% of the undersigned’s Participant’s Basic Compensation, maximum 6% of the undersigned’s Participant’s Basic Compensation, in whole percentages only), to be calculated accordingly and deducted per Pay Period pursuant to the terms of such Plan.

            Whenever used herein, any words or terms not otherwise defined in this Instrument Changing Employee Contribution Level, but defined in the Plan, shall have the meanings ascribed thereto in the Plan.

DATED as of the ______ day of ______________, 20_____.

 

     
(Witness)   (Signature of Employee)
     
     
     
(Account Number)   (Please Print Name)
     
     
     
    (Please Print Address)

17


Appendix C – Form of Withdrawal, Transfer or Sale of Shares
Employee Share Purchase Plan
effective __________________, 2008

To: COUNTERPATH CORPORATION (the “Company”),
Attention: Trustee, Employee Share Purchase Plan  

In connection with the Company’s employee share purchase plan (the “Plan”) and pursuant to the terms of the Plan, the undersigned employee hereby requests to:

  [   ] (1)

withdraw __________ Shares from the undersigned’s account and register such Shares in the undersigned’s name and delivered to the undersigned’s address below;

     

 

  [   ] (2)

transfer __________ Shares from the undersigned’s account to _______________________________________, registered as follows _______________________________________________________________________;

     

 

  [   ] (3)

sell __________ Shares from the undersigned’s account and forward the proceeds (net of fees, commissions and withholding taxes) to the undersigned by cheque at the address below;

     

 

  [   ] (4)

sell __________ Shares from the undersigned’s account and transfer the proceeds (net of fees and commissions) to another RRSP Account or TFSA Account as set out below; and

     

 

  [   ] (5)

transfer __________ Shares from the undersigned’s account to another RRSP Account or TFSA Account as set out below.

For requests to transfer Shares or cash to another financial institution:

  Institution Name:  
     
  Institution Address:  
     
  Contact Name:  
     
  Contact Phone Number:  
     
  CUID:  
     
  RRSP/TFSA Account Details:  
     
  Account Number:  

In the past 12 months, this withdrawal, transfer or sale is my:

  First  
     
  Second

(I understand that I am restricted from making further contributions to, or withdrawals, transfers or sales from, the Plan for a period of 12 months from the date of this withdrawal, transfer or sale)

     
  Third

(I understand that I must terminate my membership in the Plan with this withdrawal, transfer or sale)

18


Whenever used herein, any words or terms not otherwise defined in this Withdrawal, Transfer or Sale of Shares, but defined in the Plan, shall have the meanings ascribed thereto in the Plan.

DATED as of the ______ day of ______________, 20_____.

 

     
(Witness)   (Signature of Employee)
     
     
     
(Account Number)   (Please Print Name)
     
     
     
    (Please Print Address)

The Company hereby authorizes the above withdrawal, transfer or sale by the Trustee.

  COUNTERPATH CORPORATION
   
   
  Per:            ______________________________________________
                     Name: _______________________________
                     Title:   _______________________________

19


Appendix D – Form of Instrument Suspending Contributions
Employee Share Purchase Plan
effective __________________, 2008

To: COUNTERPATH CORPORATION (the “Company”)
  Attention: Trustee, Employee Share Purchase Plan (the “Plan”)

            The undersigned employee hereby elects to suspend the undersigned’s contributions to the Plan until further notice, pursuant to the terms of the Plan.

DATED as of the ______ day of ______________, 20_____.

 

     
(Witness)   (Signature of Employee)
     
     
     
(Account Number)   (Please Print Name)
     
     
     
    (Please Print Address)

20


Appendix E – Form of Instrument Resuming Contributions
Employee Share Purchase Plan
effective __________________, 2008

To: COUNTERPATH CORPORATION (the “Company”)
  Attention: Trustee, Employee Share Purchase Plan (the “Plan”)

            The undersigned employee hereby requests to resume the undersigned’s contribution to the Company’s employee share purchase plan (the “Plan”) in an the amount of ______ % of the undersigned’s Participant’s Basic Compensation (minimum of 1% of the undersigned’s Participant’s Basic Compensation, maximum 6% of the undersigned’s Participant’s Basic Compensation, in whole percentages only), pursuant to the Plan.

            Whenever used herein, any words or terms not otherwise defined in this Instrument Resuming Contributions, but defined in the Plan, shall have the meanings ascribed thereto in the Plan.

DATED as of the ______ day of ______________, 20_____.

 

     
(Witness)   (Signature of Employee)
     
     
     
(Account Number)   (Please Print Name)
     
     
     
    (Please Print Address)

21


Appendix F – Form of Instrument Cancelling Participation
Employee Share Purchase Plan
effective __________________, 2008

To: COUNTERPATH CORPORATION (the “Company”)
  Attention: Trustee, Employee Share Purchase Plan (the “Plan”)

            The undersigned employee hereby gives notice to, and directs, the Company to cancel the undersigned’s Election to Purchase Shares and the undersigned’s participation in the Plan, pursuant to the terms of the Plan.

            The undersigned hereby directs the Company and the Trustee to forward the assets in my account to which I am entitled pursuant to the terms of the Plan as follows:

  [   ] (1)

Please forward a share certificate to me, registered in my name as set forth below, for all of the Shares in my Account to which I am entitled. I understand that any fractional shares in my account will be converted to cash and forwarded to me, with any cash in my account, by cheque.

       
  [   ] (2)

Please transfer all of the Shares in my account to which I am entitled to ___________________________, at the following address, ___________________________________________ ____________________________________________ registered as follows _____________________________________________________. I understand that any fractional shares in my account will be converted to cash and forwarded to me, with any cash in my account, by cheque.

       
  [   ] (3)

Please sell all of the Shares in my account to which I am entitled and forward the proceeds (net of fees and commissions) to me by cheque.

DATED as of the ______ day of ______________, 20_____.

 

     
(Witness)   (Signature of Employee)
     
     
     
(Account Number)   (Please Print Name)
     
     
     
    (Please Print Address)

22



COUNTERPATH CORPORATION

AMENDED 2010 STOCK OPTION PLAN

                          This 2010 Stock Option Plan (the "Plan") provides for the grant of options to acquire shares of common stock, no par value (the "Common Stock"), of CounterPath Corporation, a Nevada company (the "Company"). For the purposes of Eligible Employees (as defined below) who are subject to tax in the United States, stock options granted under this Plan that qualify under Section 422 of the United States Internal Revenue Code of 1986, as amended (the "Code"), are referred to in this Plan as "Incentive Stock Options". Incentive Stock Options and stock options that do not qualify under Section 422 of the Code ("Non-Qualified Stock Options") and stock options granted to non-United States residents under this Plan are referred to collectively as "Options".

1.                         PURPOSE

1.1                     The purpose of this Plan is to retain the services of valued key employees and consultants of the Company and such other persons as the Plan Administrator shall select in accordance with Section 3 below, and to encourage such persons to acquire a greater proprietary interest in the Company, thereby strengthening their incentive to achieve the objectives of the shareholders of the Company, and to serve as an aid and inducement in the hiring of new employees and to provide an equity incentive to consultants and other persons selected by the Plan Administrator.

1.2                     This Plan shall at all times be subject to all legal requirements relating to the administration of stock option plans, if any, under applicable Canadian federal and provincial, and United States federal and state securities laws, the Code, the rules of any applicable stock exchange or stock quotation system, and the rules of any foreign jurisdiction applicable to Options granted to residents therein (collectively, the "Applicable Laws").

2.                        ADMINISTRATION

2.1                    This Plan shall be administered initially by the Board of Directors of the Company (the "Board"), except that the Board may, in its discretion, establish a committee composed of two (2) or more members of the Board to administer the Plan, which committee (the "Committee") may be an executive, compensation or other committee, including a separate committee especially created for this purpose. The Board or, if applicable, the Committee is referred to herein as the "Plan Administrator".

2.2                    If and so long as the Common Stock is registered under Section 12(b) or 12(g) of the United States Securities Exchange Act of 1934, as amended (the "Exchange Act"), the Board shall consider in selecting the Plan Administrator and the membership of any Committee, with respect to any persons subject or likely to become subject to Section 16 of the Exchange Act, the provisions regarding (a) "outside directors" as contemplated by Section 162(m) of the Code, and (b) "Non-Employee Directors" as contemplated by Rule 16b-3 under the Exchange Act.

2.3                    The Committee shall have the powers and authority vested in the Board hereunder (including the power and authority to interpret any provision of the Plan or of any Option). The members of any such Committee shall serve at the pleasure of the Board. A majority of the members of the Committee shall constitute a quorum, and all actions of the Committee shall be taken by a majority of the members present. Any action may be taken by a written instrument signed by all of the members of the Committee and any action so taken shall be fully effective as if it had been taken at a meeting.

2.4                    The Board may at any time amend, suspend or terminate the Plan, subject to such shareholder approval as may be required by Applicable Laws, including the rules of an applicable stock exchange or other national market system, provided that:

  (a)

no Options may be granted during any suspension of the Plan or after termination of the Plan; and



- 2 -

  (b)

any amendment, suspension or termination of the Plan will not affect Options already granted, and such Options will remain in full force and affect as if the Plan had not been amended, suspended or terminated, unless mutually agreed otherwise between the Optionee (as defined below) and the Plan Administrator, which agreement will have to be in writing and signed by the Optionee and the Company.

2.5                     Subject to the provisions of this Plan, and with a view to effecting its purpose, the Plan Administrator shall have sole authority, in its absolute discretion, to:

  (a)

construe and interpret this Plan;

     
  (b)

define the terms used in the Plan;

     
  (c)

prescribe, amend and rescind the rules and regulations relating to this Plan;

     
  (d)

correct any defect, supply any omission or reconcile any inconsistency in this Plan;

     
  (e)

grant Options under this Plan;

     
  (f)

determine the individuals to whom Options shall be granted under this Plan and whether the Option is an Incentive Stock Option or a Non-Qualified Stock Option, or otherwise;

     
  (g)

determine the time or times at which Options shall be granted under this Plan;

     
  (h)

determine the number of shares of Common Stock subject to each Option, the exercise price of each Option, the duration of each Option and the times at which each Option shall become exercisable;

     
  (i)

determine all other terms and conditions of the Options; and

     
  (j)

make all other determinations and interpretations necessary and advisable for the administration of the Plan.

2.6                     All decisions, determinations and interpretations made by the Plan Administrator shall be binding and conclusive on all participants in the Plan and on their legal representatives, heirs and beneficiaries, subject to any contrary determination by the Board.

3.                        ELIGIBILITY

3.1                     Incentive Stock Options may be granted to any individual who, at the time the Option is granted, is an employee of the Company or any Related Company (as defined below) ("Eligible Employees") subject to tax in the United States.

3.2                     Non-Qualified Stock Options may be granted to Eligible Employees, Consultants, and to such other persons who are not Eligible Employees as the Plan Administrator shall select, subject to any Applicable Laws.

3.3                     Options may be granted in substitution for outstanding options of another company in connection with the merger, consolidation, acquisition of property or stock or other reorganization between such other company and the Company or any subsidiary of the Company. Options also may be granted in exchange for outstanding Options.

3.4                     Unless otherwise approved by the Plan Administrator and Disinterested Shareholders (as such term is defined in Applicable Laws), no person shall be eligible to receive in any fiscal year Options to purchase more than 5% of the outstanding shares of Common Stock (subject to adjustment as set forth in Section 5.1(m) hereof). Any person to whom an Option is granted under this Plan is referred to as an "Optionee". Any person who is the owner of an Option is referred to as a "Holder".


- 3 -

3.5                     As used in this Plan, the term "Related Company" shall mean any company (other than the Company) that is a "Parent Company" of the Company or "Subsidiary Company" of the Company, as those terms are defined in Sections 424(e) and 424(f), respectively, of the Code (or any successor provisions) and the regulations thereunder (as amended from time to time).

4.                        STOCK

4.1                     The maximum number of shares of Common Stock issuable under the Plan is 1,186,000. The number of shares with respect to which Options may be granted hereunder is subject to adjustment as set forth in Section 5.1(m) hereof. In the event that any outstanding Option expires or is terminated for any reason, the shares of Common Stock allocable to the unexercised portion of such Option may again be subject to an Option granted to the same Optionee or to a different person eligible under Section 3 of this Plan; provided however, that any cancelled Options will be counted against the maximum number of shares with respect to which Options may be granted to any particular person as set forth in Section 3 hereof.

5.                        TERMS AND CONDITIONS OF OPTIONS

5.1                     Each Option granted under this Plan shall be evidenced by a written agreement approved by the Plan Administrator (the "Agreement"). Agreements may contain such provisions, not inconsistent with this Plan, as the Plan Administrator in its discretion may deem advisable. All Options also shall comply with the following requirements:

  (a)

Number of Shares and Type of Option

       
 

Each Agreement shall state the number of shares of Common Stock to which it pertains and, for Optionees subject to tax in the United States, whether the Option is intended to be an Incentive Stock Option or a Non-Qualified Stock Option, provided that:

       
  (i)

in the absence of action to the contrary by the Plan Administrator in connection with the grant of an Option, all Options shall be Non-Qualified Stock Options;

       
  (ii)

the aggregate fair market value (determined at the Date of Grant, as defined below) of the stock with respect to which Incentive Stock Options are exercisable for the first time by an Optionee subject to tax in the United States during any calendar year (granted under this Plan and all other Incentive Stock Option plans of the Company, a Related Company or a predecessor company) shall not exceed U.S.$100,000, or such other limit as may be prescribed by the Code as it may be amended from time to time (the "Annual Limit"); and

       
  (iii)

any portion of an Option which exceeds the Annual Limit shall not be void but rather shall be a Non-Qualified Stock Option.


  (b)

Date of Grant

     
 

Each Agreement shall state the date the Plan Administrator has deemed to be the effective date of the Option for purposes of this Plan (the "Date of Grant").

     
  (c)

Option Price

     
 

Each Agreement shall state the price per share of Common Stock at which it is exercisable. The Plan Administrator shall act in good faith to establish the exercise price in accordance with Applicable Laws; provided that :



- 4 -

  (i)

the per share exercise price for an Incentive Stock Option or any Option granted to a "covered employee" as such term is defined for purposes of Section 162(m) of the Code ("Covered Employee") shall not be less than the fair market value per share of the Common Stock at the Date of Grant as determined by the Plan Administrator in good faith;

     
  (ii)

with respect to Incentive Stock Options granted to greater-than-ten percent (>10%) shareholders of the Company (as determined with reference to Section 424(d) of the Code), the exercise price per share shall not be less than one hundred ten percent (110%) of the fair market value per share of the Common Stock at the Date of Grant as determined by the Plan Administrator in good faith;

     
  (iii)

Options granted in substitution for outstanding options of another company in connection with the merger, consolidation, acquisition of property or stock or other reorganization involving such other company and the Company or any subsidiary of the Company may be granted with an exercise price equal to the exercise price for the substituted option of the other company, subject to any adjustment consistent with the terms of the transaction pursuant to which the substitution is to occur; and

     
  (iv)

with respect to Non-Qualified Stock Options, the exercise price per share shall be determined by the Plan Administrator at the time the Option is granted, but such price shall not be less than the closing trading price of the Common Stock on the OTCBB on the last trading day preceding the date on which the Option is granted (or if the Common Stock is not then listed and posted for trading on the OTCBB, on such other stock exchange on which the Common Shares are listed and posted for trading as may be selected by the Board of Directors). In the event that the Common Stock is not listed and posted for trading on any stock exchange or other quotation systems, the exercise price shall be the fair market value of the Common Stock as determined by the Plan Administrator.


  (d)

Duration of Options

       
 

At the time of the grant of the Option, the Plan Administrator shall designate, subject to paragraph 5.1(g) below, the expiration date of the Option, which date shall not be later than ten (10) years from the Date of Grant; provided , that: (a) the expiration date of any Incentive Stock Option granted to a greater-than-ten percent (>10%) shareholder of the Company (as determined with reference to Section 424(d) of the Code) shall not be later than five (5) years from the Date of Grant, and (b) if the expiration date falls on a date which is not a business day, then the expiration date shall be extended to the end of the next business day. In the absence of action to the contrary by the Plan Administrator in connection with the grant of a particular Option, and except in the case of Incentive Stock Options as described above, all Options granted under this Plan shall expire five (5) years from the Date of Grant.

       
  (e)

Vesting Schedule

       
 

No Option shall be exercisable until it has vested. The vesting schedule for each Option shall be specified by the Plan Administrator at the time of grant of the Option prior to the provision of services with respect to which such Option is granted; provided that if no vesting schedule is specified at the time of grant, the Option shall vest as follows:

       
  (i)

on the first anniversary of the Date of Grant, the Option shall vest and shall become exercisable with respect to 25% of the Common Stock to which it pertains;

       
  (ii)

on the second anniversary of the Date of Grant, the Option shall vest and shall become exercisable with respect to an additional 25% of the Common Stock to which it pertains;



- 5 -

  (iii)

on the third anniversary of the Date of Grant, the Option shall vest and shall become exercisable with respect to an additional 25% of the Common Stock to which it pertains; and

     
  (iv)

on the fourth anniversary of the Date of Grant, the Option shall vest and shall become exercisable with respect to balance of the Common Stock to which it pertains.


 

The Plan Administrator may specify a vesting schedule for all or any portion of an Option based on the achievement of performance objectives established in advance of the commencement by the Optionee of services related to the achievement of the performance objectives. Performance objectives shall be expressed in terms of one or more of the following: return on equity, return on assets, share price, market share, sales, earnings per share, costs, net earnings, net worth, inventories, cash and cash equivalents, gross margin or the Company's performance relative to its internal business plan, or such other terms as determined and directed by the Board. Performance objectives may be in respect of the performance of the Company as a whole (whether on a consolidated or unconsolidated basis), a Related Company, or a subdivision, operating unit, product or product line of either of the foregoing. Performance objectives may be absolute or relative and may be expressed in terms of a progression or a range. An Option that is exercisable (in full or in part) upon the achievement of one or more performance objectives may be exercised only following written notice to the Optionee and the Company by the Plan Administrator that the performance objective has been achieved.

     
  (f)

Acceleration of Vesting

     
 

The vesting of one or more outstanding Options may be accelerated by the Plan Administrator at such times and in such amounts as it shall determine in its sole discretion. The vesting of Options also shall be accelerated under the circumstances described in Section 5.1(m) below.

     
  (g)

Term of Option


  (i)

Options that have vested as specified by the Plan Administrator or in accordance with this Plan, shall terminate, to the extent not previously exercised, upon the occurrence of the first of the following events:


  A.

the expiration of the Option, as designated by the Plan Administrator in accordance with Section 5.1(d) above;

     
  B.

the date of an Optionee's termination of employment or contractual relationship with the Company or any Related Company for cause (as determined in the sole discretion of the Plan Administrator);

     
  C.

the expiration of three (3) months from the date of an Optionee's termination of employment or contractual relationship with the Company or any Related Company for any reason whatsoever other than cause, death or Disability (as defined below); or

     
  D.

the expiration of one year (1) from termination of an Optionee's employment or contractual relationship by reason of death or Disability (as defined below).


  (ii)

Upon the death of an Optionee, any vested Options held by the Optionee shall be exercisable only by the person or persons to whom such Optionee's rights under such Option shall pass by the Optionee's will or by the laws of descent and distribution of the Optionee's domicile at the time of death and only until such Options terminate as provided above.



- 6 -

  (iii)

For purposes of the Plan, unless otherwise defined in the Agreement, "Disability" shall mean medically determinable physical or mental impairment which has lasted or can be expected to last for a continuous period of not less than six (6) months or that can be expected to result in death. The Plan Administrator shall determine whether an Optionee has incurred a Disability on the basis of medical evidence acceptable to the Plan Administrator. Upon making a determination of Disability, the Plan Administrator shall, for purposes of the Plan, determine the date of an Optionee's termination of employment or contractual relationship.

     
  (iv)

Unless accelerated in accordance with Section 5.1(f) above, unvested Options shall terminate immediately upon the Optionee resigning from or the Company terminating the Optionee’s employment or contractual relationship with the Company or any Related Company for any reason whatsoever, including death or Disability.

     
  (v)

For purposes of this Plan, transfer of employment between or among the Company and/or any Related Company shall not be deemed to constitute a termination of employment with the Company or any Related Company. For purposes of this subsection, employment shall be deemed to continue while the Optionee is on military leave, sick leave or other bona fide leave of absence (as determined by the Plan Administrator). The foregoing notwithstanding, employment shall not be deemed to continue beyond the first ninety (90) days of such leave, unless the Optionee's re-employment rights are guaranteed by statute or by contract.


  (h)

Exercise of Options

       
  (i)

Options shall be exercisable, in full or in part, at any time after vesting, until termination. If less than all of the shares included in the vested portion of any Option are purchased, the remainder may be purchased at any subsequent time prior to the expiration of the Option term. No portion of any Option for less than fifty (50) shares (as adjusted pursuant to Section 5.1(m) below) may be exercised; provided , that if the vested portion of any Option is less than fifty (50) shares, it may be exercised with respect to all shares for which it is vested. Only whole shares may be issued pursuant to an Option, and to the extent that an Option covers less than one (1) share, it is unexercisable.

       
  (ii)

Options or portions thereof may be exercised by giving written notice to the Company, which notice shall specify the number of shares to be purchased, and be accompanied by payment in the amount of the aggregate exercise price for the Common Stock so purchased, which payment shall be in the form specified in Section 5.1(i) below. The Company shall not be obligated to issue, transfer or deliver a certificate of Common Stock to the Holder of any Option, until provision has been made by the Holder, to the satisfaction of the Company, for the payment of the aggregate exercise price for all shares for which the Option shall have been exercised and for satisfaction of any tax withholding obligations associated with such exercise.

       
  (iii)

During the lifetime of an Optionee, Options are exercisable only by the Optionee or in the case of a Non-Qualified Stock Option, transferee who takes title to such Option in the manner permitted by subsection 5.1(k) hereof.


  (i)

Payment upon Exercise of Option

     
 

Upon the exercise of any Option, the aggregate exercise price shall be paid to the Company in cash or by certified or cashier's check. In addition, if pre-approved in writing by the Plan Administrator who may arbitrarily withhold consent, the Holder may pay for all or any portion of the aggregate exercise price by complying with one or more of the following alternatives:



- 7 -

  (i)

by delivering to the Company shares of Common Stock previously held by such Holder, or by the Company withholding shares of Common Stock otherwise deliverable pursuant to exercise of the Option, which shares of Common Stock received or withheld shall have a fair market value at the date of exercise (as determined by the Plan Administrator) equal to the aggregate exercise price to be paid by the Optionee upon such exercise; or

     
  (ii)

by complying with any other payment mechanism approved by the Plan Administrator at the time of exercise.


  (j)

No Rights as a Shareholder

     
 

A Holder shall have no rights as a shareholder with respect to any shares covered by an Option until such Holder becomes a record holder of such shares, irrespective of whether such Holder has given notice of exercise. Subject to the provisions of Section 5.1(m) hereof, no rights shall accrue to a Holder and no adjustments shall be made on account of dividends (ordinary or extraordinary, whether in cash, securities or other property) or distributions or other rights declared on, or created in, the Common Stock for which the record date is prior to the date the Holder becomes a record holder of the shares of Common Stock covered by the Option, irrespective of whether such Holder has given notice of exercise.

     
  (k)

Transfer of Option


  (i)

Options granted under this Plan and the rights and privileges conferred by this Plan may not be transferred, assigned, pledged or hypothecated in any manner (whether by operation of law or otherwise) other than by will or by applicable laws of descent and distribution or pursuant to a qualified domestic relations order, and shall not be subject to execution, attachment or similar process; provided however that, subject to applicable laws:

       
  A.

for Incentive Stock Options, any Agreement may provide or be amended to provide that a Non-Qualified Stock Option to which it relates is transferable without payment of consideration to immediate family members of the Optionee or to trusts or partnerships or limited liability companies established exclusively for the benefit of the Optionee and the Optionee's immediate family members; or

       
  B.

for Non-Qualified Stock Options, the Optionee's heirs or administrators may exercise any portion of the outstanding Options within one year of the Optionee's death.


  (ii)

Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of any Option or of any right or privilege conferred by this Plan contrary to the provisions hereof, or upon the sale, levy or any attachment or similar process upon the rights and privileges conferred by this Plan, such Option shall thereupon terminate and become null and void.


  (l)

Securities Regulation and Tax Withholding

       
  (i)

Shares shall not be issued with respect to an Option unless the exercise of such Option and the issuance and delivery of such shares shall comply with all Applicable Laws. The inability of the Company to obtain from any regulatory body the authority deemed by the Company to be necessary for the lawful issuance and sale of any Options or shares under this Plan, or the unavailability of an exemption from registration for the issuance and sale of any shares under this Plan, shall relieve the Company of any liability with respect to the non-issuance or sale of such Options or shares.



- 8 -

  (ii)

As a condition to the exercise of an Option, the Plan Administrator may require the Holder to represent and warrant in writing at the time of such exercise that the shares are being purchased only for investment and without any then-present intention to sell or distribute such shares. At the option of the Plan Administrator, a stop-transfer order against such shares may be placed on the stock books and records of the Company, and a legend indicating that the stock may not be pledged, sold or otherwise transferred unless an opinion of counsel is provided stating that such transfer is not in violation of any applicable law or regulation, may be stamped on the certificates representing such shares in order to assure an exemption from registration. The Plan Administrator also may require such other documentation as may from time to time be necessary to comply with federal, provincial or state securities laws. THE COMPANY HAS NO OBLIGATION TO UNDERTAKE REGISTRATION OF OPTIONS OR THE SHARES OF STOCK ISSUABLE UPON THE EXERCISE OF OPTIONS.

     
  (iii)

The Holder shall pay to the Company by certified or cashier's check, promptly upon exercise of an Option or, if later, the date that the amount of such obligations becomes determinable, all applicable federal, state, provincial, local and foreign withholding taxes that the Plan Administrator, in its discretion, determines to result upon exercise of an Option or from a transfer or other disposition of shares of Common Stock acquired upon exercise of an Option or otherwise related to an Option or shares of Common Stock acquired in connection with an Option. Upon approval of the Plan Administrator, a Holder may satisfy such obligation by complying with one or more of the following alternatives selected by the Plan Administrator:


  A.

by delivering to the Company shares of Common Stock previously held by such Holder or by the Company withholding shares of Common Stock otherwise deliverable pursuant to the exercise of the Option, which shares of Common Stock received or withheld shall have a fair market value at the date of exercise (as determined by the Plan Administrator) equal to any withholding tax obligations arising as a result of such exercise, transfer or other disposition; or

     
  B.

by complying with any other payment mechanism approved by the Plan Administrator from time to time.


  (iv)

The issuance, transfer or delivery of certificates of Common Stock pursuant to the exercise of Options may be delayed, at the discretion of the Plan Administrator, until the Plan Administrator is satisfied that the applicable requirements of the federal, provincial and state securities laws and the withholding provisions under Applicable Laws have been met and that the Holder has paid or otherwise satisfied any withholding tax obligation as described in paragraph 5.1(l)(iii) above.


  (m)

Stock Dividend or Reorganization

       
  (i)

If: (1) the Company shall at any time be involved in a transaction described in Section 424(a) of the Code (or any successor provision) or any "corporate transaction" described in the regulations thereunder; (2) the Company shall declare a dividend payable in, or shall subdivide, reclassify, reorganize, or combine, its Common Stock; or (3) any other event with substantially the same effect shall occur, the Plan Administrator shall, subject to applicable law, with respect to each outstanding Option, proportionately adjust the number of shares of Common Stock subject to such Option and/or the exercise price per share so as to preserve the rights of the Holder substantially proportionate to the rights of the Holder prior to such event, and to the extent that such action shall include an increase or decrease in the number of shares of Common Stock subject to outstanding Options, the number of shares available under Section 4 of this Plan and the exercise price for such Options shall automatically be increased or decreased, as the case may be, proportionately, without further action on the part of the Plan Administrator, the Company, the Company's shareholders, or any Holder, so as to preserve the proportional rights of the Holder.



- 9 -

  (ii)

In the event that the presently authorized capital stock of the Company is changed into the same number of shares with a different par value, or without par value, the stock resulting from any such change shall be deemed to be Common Stock within the meaning of the Plan, and each Option shall apply to the same number of shares of such new stock as it applied to old shares immediately prior to such change.

     
  (iii)

If the Company shall at any time declare an extraordinary dividend with respect to the Common Stock, whether payable in cash or other property, the Plan Administrator may, subject to applicable law, in the exercise of its sole discretion and with respect to each outstanding Option, proportionately adjust the number of shares of Common Stock subject to such Option and/or adjust the exercise price per share so as to preserve the rights of the Holder substantially proportionate to the rights of the Holder prior to such event, and to the extent that such action shall include an increase or decrease in the number of shares of Common Stock subject to outstanding Options, the number of shares available under Section 4 of this Plan shall automatically be increased or decreased, as the case may be, proportionately, without further action on the part of the Plan Administrator, the Company, the Company's shareholders, or any Holder.

     
  (iv)

The foregoing adjustments in the shares subject to Options shall be made by the Plan Administrator, or by any successor administrator of this Plan, or by the applicable terms of any assumption or substitution document.

     
  (v)

The grant of an Option shall not affect in any way the right or power of the Company to make adjustments, reclassifications, reorganizations or changes of its capital or business structure, to merge, consolidate or dissolve, to liquidate or to sell or transfer all or any part of its business or assets.

6.                         EFFECTIVE DATE; SHAREHOLDER APPROVAL

6.1                     Incentive Stock Options may be granted by the Plan Administrator from time to time on or after the date on which this Plan is adopted (the "Effective Date") through the day immediately preceding the tenth anniversary of the Effective Date.

6.2                     Non-Qualified Stock Options may be granted by the Plan Administrator on or after the Effective Date and until this Plan is terminated by the Board in its sole discretion.

6.3                     Termination of this Plan shall not terminate any Option granted prior to such termination.

6.4                     The approval of Disinterested Shareholders will be obtained for any reduction in the exercise price of Options if the Optionee is an Insider of the Company at the time of the proposed amendment. The terms "Disinterested Shareholder" and "Insider" shall have the meanings as defined for those terms in the Applicable Laws.

6.5                     Any Options granted by the Plan Administrator prior to the approval of this Plan by the shareholders of the Company shall be granted subject to ratification of this Plan by the shareholders of the Company within twelve (12) months before or after the Effective Date. If such shareholder ratification is sought and not obtained, all Options granted prior thereto and thereafter shall be considered Non-Qualified Stock Options and any Options granted to Covered Employees will not be eligible for the exclusion set forth in Section 162(m) of the Code with respect to the deductibility by the Company of certain compensation. In addition, any such Options will remain unvested unless and until shareholder approval is obtained.


- 10 -

7.                        NO OBLIGATIONS TO EXERCISE OPTION

7.1                     The grant of an Option shall impose no obligation upon the Optionee to exercise such Option.

8.                        NO RIGHT TO OPTIONS OR TO EMPLOYMENT

8.1                     Whether or not any Options are to be granted under this Plan shall be exclusively within the discretion of the Plan Administrator, and nothing contained in this Plan shall be construed as giving any person any right to participate under this Plan.

8.2                     The grant of an Option shall in no way constitute any form of agreement or understanding binding on the Company or any Related Company, express or implied, that the Company or any Related Company will employ or contract with an Optionee for any length of time, nor shall it interfere in any way with the Company's or, where applicable, a Related Company's right to terminate Optionee's employment at any time, which right is hereby reserved.

9.                        APPLICATION OF FUNDS

9.1                     The proceeds received by the Company from the sale of Common Stock issued upon the exercise of Options shall be used for general corporate purposes, unless otherwise directed by the Board.

10.                      INDEMNIFICATION OF PLAN ADMINISTRATOR

10.1                   In addition to all other rights of indemnification they may have as members of the Board, members of the Plan Administrator shall be indemnified by the Company for all reasonable expenses and liabilities of any type or nature, including attorneys' fees, incurred in connection with any action, suit or proceeding to which they or any of them are a party by reason of, or in connection with, this Plan or any Option granted under this Plan, and against all amounts paid by them in settlement thereof (provided that such settlement is approved by independent legal counsel selected by the Company), except to the extent that such expenses relate to matters for which it is adjudged that such Plan Administrator member is liable for willful misconduct; provided, that within fifteen (15) days after the institution of any such action, suit or proceeding, the Plan Administrator member involved therein shall, in writing, notify the Company of such action, suit or proceeding, so that the Company may have the opportunity to make appropriate arrangements to prosecute or defend the same.

11.                       AMENDMENT OF PLAN

11.1                   The Plan Administrator may, subject to Applicable Laws, at any time, modify, amend or terminate this Plan or modify or amend Options granted under this Plan, including, without limitation, such modifications or amendments as are necessary to maintain compliance with applicable statutes, rules or regulations; provided however that:

  (a)

no amendment with respect to an outstanding Option which has the effect of reducing the benefits afforded to the Holder thereof shall be made over the objection of such Holder;

     
  (b)

the events triggering acceleration of vesting of outstanding Options may be modified, expanded or eliminated without the consent of Holders;

     
  (c)

the Plan Administrator may condition the effectiveness of any such amendment on the receipt of shareholder approval at such time and in such manner as the Plan Administrator may consider necessary for the Company to comply with or to avail the Company and/or the Optionees of the benefits of any securities, tax, market listing or other administrative or regulatory requirement; and

     
  (d)

the Plan Administrator may not increase the number of shares available for issuance on the exercise of Incentive Stock Options without shareholder approval.



- 11 -

11.2                   Without limiting the generality of Section 11.1 hereof, the Plan Administrator may modify grants to persons who are eligible to receive Options under this Plan who are foreign nationals or employed outside Canada and the United States to recognize differences in local law, tax policy or custom.

Effective Date: September 27, 2011 as amended July 10, 2014, September 12, 2016 and October 22, 2018.



 
Suite 300, One Bentall Centre
505 Burrard Street
Vancouver, BC, Canada
V7X 1M3
www.counterpath.com

WITHOUT PREJUDICE

Personal, Private & Confidential

Delivered by Email

September 17, 2018

Donovan Jones
 

Dear Donovan:

Re: Resignation of Employment

This letter will confirm the terms and conditions of Donovan Jones’s (“ Jones ”) separation from his employment as President and Chief Executive Officer of CounterPath Corporation and as an Officer and Director of CounterPath Technologies Inc. and BridgePort Networks Inc. and any other subsidiaries or affiliates (“ CounterPath ”) effective September 18, 2018 (the “ Separation Date ”), and CounterPath has accepted his resignation.

The following terms have been agreed upon:

1.           Resignation

Jones will provide confirmation in writing of his resignation as President and Chief Executive Officer of CounterPath Corporation by September 17, 2018, effective the Separation Date. In addition, Jones will provide confirmation in writing of his resignation from his roles as Officer and Director of any of CounterPath Corporation’s subsidiaries or affiliates by September 17, 2018, effective the Separation Date, by completing and executing the form attached as Schedule “A” to this document.

1


On the Separation Date, Jones will be paid the balance of any outstanding wages. Any accrued and unused vacation up to the Separation Date shall be forfeited. Jones’s Record of Employment will be provided shortly.

2.           Salary Continuance

CounterPath will pay Jones his regular base salary (not including car allowance) less the normal statutory deductions (the “ Salary Continuance ”) for twelve (12) months commencing on the first payroll following September 18, 2018 until September 18, 2019, in accordance with CounterPath’s regular pay schedule (the “ Salary Continuance Period ”). As of September 18, 2019, all payments will cease and Jones will not be entitled to any further compensation or payments of any type including vacation pay.

3.           Benefits

Jones’s group benefit coverage for MSP, healthcare, dental care, life insurance, AD&D insurance, critical illness insurance and disability benefits will end on the Separation Date. CounterPath will extend Jones’s existing dental care and healthcare excluding out of country and global medical assistance coverage (through Great Life) for twelve (12) months until the end of the Salary Continuance Period on September 18, 2019. CounterPath will also continue Jones’s MSP coverage until September 30, 2019. In the event Jones secures replacement employment prior to September 30, 2019, Jones must notify CounterPath and his remaining benefits will cease.

Jones’s disability insurance policy #41223303 will end on the Separation Date. To inquire about converting this and any of the other group benefits to a personal plan beyond the Separation Date, Jones may contact Benefit Insurance at 1-613-727-0424.

4.           Confidentiality and Non-Competition Agreement

It is a condition of the acceptance of this Agreement that Jones execute the attached Confidentiality/Non-Competition and Non-Solicitation Agreement. For clarity, where there is any inconsistency between the attached Confidentiality/Non-Competition and Non-Solicitation Agreement and the previous Confidentiality and Non-Competition Agreement which Jones signed on June 1, 2005, the terms of the attached Confidentiality/Non-Competition and Non-Solicitation Agreement will prevail.

2


It is a further condition of the acceptance of this Agreement that Jones agree to abide by these obligations. For clarity, Jones cannot work for or provide any services to any CounterPath competitors for 18 months commencing on September 18, 2018. In the event that Jones breaches these obligations, including by accepting employment from a competitor such as DialPad Inc., Slack Technologies, or from a division within a company competing with CounterPath, the Salary Continuance will immediately cease and CounterPath will take immediate steps to enforce the Confidentiality/Non-Competition and Non-Solicitation Agreement and this Agreement. For clarity, in the event that Jones breaches any of these obligations during the Salary Continuance Period or after the Salary Continuance Period ceases, CounterPath also reserves the right to pursue any other rights or remedies it may have against Jones, including but not limited to an injunction and an action for damages.

It is a further condition of the acceptance of this Agreement that Jones keep the terms of this Agreement strictly confidential and that Jones does not disclose any information with respect to this Agreement to anyone with the exception of Jones’s spouse and his legal or financial advisors, unless compelled to do so by law or court order.

5.           Stock Options and Deferred Share Units:

Jones has been granted stock options pursuant to CounterPath’s 2010 Stock Option Plan, of which 99,583 stock options will be deemed to be vested on September 18, 2018, and can be exercised by Jones for up to and including 90 days from the Separation Date.

Jones has been granted deferred share units (DSUs) pursuant to the Company’s 2010 Stock Option Plan, of which 137,706 DSUs will be deemed to be vested on September 18, 2018, and shall be converted to common shares on the distribution date(s) indicated by Jones on the attached Schedule “B”. Failure to provide specified distribution dates shall result in the Company converting vested DSUs on December 31, 2019.

3


6.           Business Expenses, Laptop and Smartphone

All reasonable business expenses incurred by Jones up to and including September 18, 2018 will be reimbursed to him upon providing CounterPath with the appropriate forms and supporting original receipts. All outstanding reasonable business expenses must be submitted by no later than September 30, 2018. Jones may keep his CounterPath laptop and smartphone, provided that CounterPath’s IT department has downloaded and saved company files, and then deleted company files.

7.           Non-Disparagement

It is a condition of the acceptance of this Agreement that Jones does not make any disparaging remarks about CounterPath, its affiliates, directors, officers, shareholders, employees, owners, clients, suppliers, services or products to any person or do anything that would damage or interfere with CounterPath’s relationships with any former, current, or prospective directors, officers, employees, contractors, owners, clients, customers, suppliers, or agents.

CounterPath’s employees and officers who have knowledge regarding the cessation of Jones’s employment with CounterPath will, to the extent it is within their knowledge and control, refrain from making any disparaging remarks about Jones.

8.           Reference Letter

CounterPath agrees to provide Jones with a positive written reference letter, the language of which will be determined by CounterPath in its sole discretion. CounterPath agrees to respond to any inquiries in reference to Jones in a manner consistent with the language in the written reference letter.

9.           Mutual Release

This Agreement is made in full and final satisfaction of any and all claims that Jones may have as against CounterPath. Accordingly, it is a condition of the acceptance of this Agreement that Jones confirm his acceptance of this Agreement by providing CounterPath with a signed copy of this letter and an executed copy of the attached full and final Release of all claims by the close of business on September 18, 2018.

4


CounterPath will agree to release and discharge Jones from any actions arising from Jones’s employment with CounterPath and the cessation of Jones’s employment with CounterPath with the exceptions set out in the Mutual Release.

Jones has been given the opportunity to seek legal advice with respect to this Agreement.

If there are any questions with respect to this letter, please feel free to contact the writer.

Yours truly,

CounterPath Corporation
CounterPath Technologies Inc.

Per:

/s/ Steven Bruk

Steven Bruk,

Director

Jones has been given a copy of this letter. Jones has read, understood and hereby accepts its terms and conditions.

 

Accepted /s/ Donovan Jones   September 17, 2018
  Donovan Jones   Date
       
  /s/ Steven Bruk   September 17, 2018
  CounterPath Corporation   Date

5


MUTUAL RELEASE

Donovan Jones (“ Jones ”) for the consideration set out in the attached letter dated September 17, 2018 and for other good and valuable consideration, does forever release and forever discharge CounterPath Corporation together with its affiliates, subsidiaries, directors, officers, employees, agents, owners and shareholders (collectively “ CounterPath ”) from any and all manners of actions, causes of actions, suits, contracts, claims, complaints, damages, costs and expenses of any nature or kind whatsoever known or unknown whether in law or in equity or pursuant to statute, which, as against CounterPath, Jones has ever had or now has by reason of or arising out of any cause, matter or thing whatsoever occurring or existing up to the date of execution of this Release and without limiting the generality of the foregoing, any matter, cause, or thing relating to or arising out of Jones’s employment with CounterPath, his contract of employment with CounterPath, or the cessation of Jones’s employment with CounterPath, and any other claim for damages, notice, payment in lieu of notice, wrongful dismissal, severance pay, loss of benefits including life and long-term and short-term disability, pension issues, bonus, profit sharing, stock distribution, stock options or stock purchase rights, overtime pay, vacation pay or any claims under the British Columbia Employment Standards Act or Human Rights Code .

CounterPath, in exchange for this Mutual Release and other good and valuable consideration, does release and discharge Jones from any and all matters of actions, causes of actions, suits, contracts, claims, complaints, damages, cost and expenses known to CounterPath, which, as against Jones, CounterPath has ever had or now has up to the date of this Mutual Release and without limiting the generality of the forgoing, any matter, cause or thing relating to or arising out of Jones’s employment with CounterPath, his contract of employment with CounterPath or the cessation of Jones’s employment with CounterPath. Notwithstanding the forgoing, CounterPath does not release Jones from any and all manners of actions, causes of actions, suits, contracts, claims, complaints, damages, costs and expenses arising out of any criminal conduct by Jones, or any breaches of the obligations set out in section 4 of the attached letter dated September 17, 2018.

6


Jones covenants and undertakes that he will not file any complaint for termination or severance pay, overtime or vacation pay or make any other claim pursuant to the British Columbia

Employment Standards Act .

Jones acknowledges that he has received all payments and amounts owing to him under the Employment Standards Act and that the payments made to him herein are in full and final satisfaction of any further entitlements he may have pursuant to the Employment Standards Act .

Jones acknowledges that he has not been subjected to any form of discrimination whatsoever and hereby represents and warrants that he has not commenced any complaint and undertakes not to commence any complaint under the British Columbia Human Rights Code or Workers Compensation Act .

This Release is binding upon and enures to the benefit of Jones’s heirs, executors, administrators, assigns, committees and trustees.

This Release is binding upon and enures to the benefit of CounterPath’s affiliates, subsidiaries, directors, officers, employees, agents, predecessors, successors, assigns, liquidators, receivers, receiver managers, trustees, owners and shareholders.

In the event withholdings have not been deducted which should have been deducted, Jones shall indemnify and save harmless CounterPath from any resulting liabilities, obligations, and costs regarding any claims which Canada Revenue Agency or Employment Insurance Commission may have with respect to any payments made to or on behalf of Jones.

Jones and CounterPath acknowledge that the facts in respect of which this Release is made may prove to be other than or different from the facts in that connection now known or believed to be true. The parties accept and assumes the risk of the facts being different and agrees that this Release shall be in all respects enforceable and not subject to termination, rescission, or variation by discovery of any differences in facts.

Jones agrees to keep the terms of this settlement with CounterPath and this Release strictly confidential and will not disclose any information with respect to this settlement or this Release to anyone with the exception of Jones’ spouse and his legal or financial advisors, unless compelled to do so by law or court order.

7


The parties acknowledge that this Release has been executed voluntarily after receiving legal advice.

The Release is given voluntarily for the purposes of making a full and final settlement of all of Jones’s and Counterpath’s claims against each other other than the exceptions set out here in.

This Release and the related settlement is a compromise of a disputed claim and is not to be construed or considered as an admission of liability by CounterPath.

8


The terms of the Release are contractual and not recitals.

Dated at Vancouver , the 17 th day of September , 2018.

SIGNED by Donovan Jones in the )  
presence of: )  
  )  
  )  
/s/ Lauren Mainman ) /s/ Donovan Jones
Witness (Name) ) Donovan Jones
  )  
  )  
  )  
Address )  
     
     
     
SIGNED by CounterPath in the presence )  
of: )  
  )  
  )  
/s/ Lauren Mainman ) /s/ Steven Bruk
Witness (Name) ) CounterPath
  )  
  )  
  )  
Address )  

9


SCHEDULE A

 

RESIGNATION OF DIRECTOR AND OFFICER

 

TO: CounterPath Corporation (the “ Corporation ”)
AND TO: CounterPath Technologies Inc. (the “ Subsidiary ”)

Effective as of September 18, 2018, I hereby resign as:

(a)

a director of the Corporation and the Subsidiary;

   
(b)

as the Chief Executive Officer and President of the Corporation;

   
(c)

as the Chief Executive Officer and President of the Subsidiary; and

   
(d)

from all other officer and director positions of the Corporation, the Subsidiary and any of their respective affiliates.


  /s/ Donovan Jones
  DONOVAN JONES

10


SCHEDULE B

 

NON-U.S. TAXPAYER: FORM OF ELECTION

FOR TIMING AND AMOUNT OF PAYMENT

THIS ELECTION FORM MUST BE RETURNED TO THE CORPORATE SECRETARY OF THE CORPORATION (AT THE FOLLOWING FAX NUMBER: (604) 320-3399 BY 5:00 P.M. (PACIFIC TIME)) PRIOR TO THE SEPARATION DATE, WITH RESPECT TO THE FIRST DISTRIBUTION DATE AND PRIOR TO THE FIRST DISTRIBUTION DATE, WITH RESPECT TO THE SECOND DISTRIBUTION DATE.

I hereby irrevocably elect the following Distribution Date(s) and Amounts.

First Distribution Date: Percentage of Deferred Share Units to
  Distribute to me on the First Distribution
                    days (minimum of 90 days) following Date:
my Separation Date.  
                        % (must be in increments of 5%)
  Will be rounded up to the nearest unit.
   
Second Distribution Date (optional): Remainder of Deferred Share Units will be
  delivered to me on the Second Distribution
                    days (minimum of 90 days) following Date.
my Separation Date.  

Please note that regardless of the elections above, if either Distribution Date falls on or after December 31 of the calendar year following the year during which the Participant’s Separation Date occurs, then the all amounts credited to a Participant’s account shall be automatically distributed on the business day that immediately precedes such December 31.

______________________________
Participant Signature

______________________________
Date

11


Confidentiality/Non-Competition and Non-Solicitation Agreement

THIS CONFIDENTIALITY/NON-COMPETITION AND NON-SOLICITATION AGREEMENT (the “ Agreement ”) dated as of the 17 th day of September, 2018.

BETWEEN:

CounterPath Corporation.
Suite 300, 505 Burrard Street, Vancouver, BC V7X 1M3
(the “ Company ”)

AND:

Donovan Jones having an address at
(“ Jones ”)

WHEREAS:

A.

The Company and Jones have entered into a Separation Agreement, the terms of which are set out in a letter dated September 17, 2018 (the “ Separation Agreement ”);

   
B.

Pursuant to the Separation Agreement, the Company provides to Jones a compensation payment and other benefits;

   
C.

Jones and Xten Networks, Inc., a predecessor to the Company, previously entered into a Confidentiality and Non- Competition Agreement (The 2005 Agreement); and

   
D.

As a condition of the Company entering into the Separation Agreement, Jones agrees to the restrictions set out in this Agreement.

NOW THEREFORE in consideration of the promises and mutual covenants and agreements set out in this Agreement and for other good and valuable consideration given by each party to the other, the receipt and sufficiency of which is hereby acknowledged by each of the Parties hereto, the Parties hereby agree as follows:

1.

CONFIDENTIALITY

   
1.1.

Non-Disclosure of Information of the Company : Jones acknowledges that by reason of his employment with the Company, Jones had access to the Confidential Information of the Company. Jones understands and acknowledges the importance of maintaining the security and confidentiality of the Confidential Information. Jones will not use or disclose the Confidential Information. Nothing in this Agreement will prevent Jones’s use or disclosure of information which is publicly available or which is required to be disclosed under applicable laws or legal process.

   
1.2.

Confidential Information : For the purposes of this Agreement, “ Confidential Information ” means all information in any form, whether written, electronic, or oral, about or owned, used or licensed by the Company or its subsidiaries, parents, affiliates and related companies and other third parties, including without limitation information about their respective businesses and projects, business interests and opportunities, financial information, credit information and pricing information, compensation data, customer lists, customer preferences, marketing and communication strategies and plans, new products and services research, pending projects and proposals, market research, research and development strategies, information relating to employees and independent contractors, assets, liabilities, software, scientific interests, customers, members, website users, suppliers and customers of their suppliers, and all other information that is treated by the Company or any of its subsidiaries, parents, affiliates and related companies as confidential information or a trade secret. Examples of Confidential Information includes, but is not limited to customer lists and information, employee information, and their salaries, strengths and weaknesses, purchasing and marketing methods and strategies. Confidential Information does not include information that is lawfully available to the public other than: (a) through Jones’s breach of this Agreement; or (b) the breach by any other person of any confidentiality obligations owed to the Company or any of its subsidiaries, parents, affiliates and related companies.

-1-



1.3.

Return of Confidential Information and Property : Jones represents that on or before September 18, 2018 he will return to the Company or destroy all originals or copies of the Confidential Information and all paper and electronic documents and other records containing Confidential Information, and any other property belonging to, or relating to the business of, the Company or its subsidiaries, parents, affiliates and related companies.

   
2.

RESTRICTED ACTIVITIES

   
2.1.

Non-Solicitation : For a period of eighteen (18) months beginning on September 18, 2018, Jones will not, directly or indirectly:


(a)

contact or communicate with any Customer for the purpose of offering for sale any products or services that are the same as or similar to those offered by the Company;

(b)

solicit, divert, or take away from the Company the business of any Customer;

(c)

service, or otherwise enter into contractual relations with, any Customer of the Company for the purpose of offering for sale any products or services that are the same as or similar to those offered by the Company; or

(d)

solicit or encourage any employee or contractor of the Company to terminate their relationship with the Company, or assist any other person or entity to do so.


2.2.

Non-Competition : For a period of eighteen (18) months beginning on September 18, 2018, Jones will not, without the prior written agreement of the Company, directly or indirectly, engage in any Prohibited Business, whether as an employee, partner, principal, agent, consultant, shareholder, lender, guarantor or otherwise, in North America.

   
2.3.

Definitions : For the purposes of this section:


(a)

“Customer” means any person to whom the Company provided products or services in the two years prior to September 18, 2018 and whom Jones knew to be a customer of the Company;

(b)

employee or contractor ” means any person who had an employment or contractor relationship with the Company in the two years prior to September 18, 2018 and with whom Jones became acquainted as a result of his employment with the Company; and

(c)

Prohibited Business ” means the development of software or provision of services for unified communications including voice and video calling, instant messaging and collaboration.

-2-



3.

TRADE SECRETS AND WORK PRODUCT

   
3.1

Assignment:

   

Jones represents that Jones had intended and agreed that the Company would own all Developments, Trade Secrets and Confidential Information (each as defined in the 2005 Agreement and all other intellectual property, materials and work product created by Jones in the course of his employment by the Company and its predecessors (all of the foregoing being hereafter referred to collectively as “ Work Product ”), together with all copyright, patent rights and other intellectual property rights of any kind whatsoever throughout the world (“ IP Rights ”), from the time of creation, and that this Section 3.1 is effective in respect of each item of Work Product as, at and from the date of its creation. Jones hereby irrevocably and unconditionally assigns and transfers to the Company all of Jones’s right, title and interest (including without limitation all IP Rights) throughout the world in, to and associated with the Work Product, free and clear of all liens, encumbrances, and interests of third parties, without any limitation of time and without any restriction whatsoever; and (b) waives in favour of the Company and its successors, assigns and licensees any and all non-transferable rights (including without limitation any and all moral rights and rights of authorship) Jones has throughout the world in, to or associated with any item of Work Product.

   
3.2

Addition to the 2005 Agreement:

   

This section is in addition to, and not in submission for the provisions of the 2005 Agreement relating to Developments, Trade Secrets and Work Product, all of which continue to be binding on Jones.

   
4.

GENERAL

   
4.1

Assignment: The Company may assign this Agreement.

   
4.2

Severability : Jones acknowledges that each provision of this Agreement is a separate and distinct covenant and if any covenant or provision herein is determined to be unreasonable, void, voidable or unenforceable, in whole or in part, by a court of competent jurisdiction, such determination will not affect or impair, and will not be deemed to affect or impair, the validity of any other covenant or provision hereof, and each covenant and provision herein is hereby declared to be separate, severable and distinct. It is the intent of the parties that if a court of competent jurisdiction adjudicating upon the validity of these covenants finds them to be unreasonable in any way, whether with respect to the scope of the restriction, the geographic area of the restriction, or the duration of the restriction, then such restriction shall be reduced to that which is deemed reasonable by such court.

   
4.3

Governing Law : This Agreement and all related matters will be governed by, and construed in accordance with, the laws of British Columbia and the laws of Canada applicable in British Columbia.

   
4.4

Other Duties : The restrictions contained in Section 1 and Section 2 of this Agreement are in addition to and do not derogate from any other duties and obligations (including fiduciary obligations) Jones owes to the Company under any applicable laws.

-3-



4.5

Succession : This Agreement and everything herein contained will enure to the benefit of and be binding upon the Parties, and their respective legal representatives, executors, administrators, trustees, receivers, receiver-managers, successors and permitted assigns.

   
4.6

Injunctive Relief : Jones acknowledges and agrees that a violation of any of the covenants contained in this Agreement will cause irreparable harm or damage to the Company, the exact amount of which would be impossible to ascertain, and for this reason, among others, the Company will be entitled to obtain injunctive relief restraining any further violations of such covenants, without the necessity of providing any undertaking as to damages or meeting any requirements for security. Jones hereby also acknowledges and agrees that, in the event of a violation of any of the covenants contained in this Agreement, an injunction is a reasonable and proper remedy. The right of the Company to any injunction or other equitable relief under this paragraph is in addition to, and not a limitation of, any other rights or remedies that the Company may have against Jones.

   
4.7

Agreement Voluntary and Equitable : The parties acknowledge that they have carefully considered and understand the terms contained in this Agreement and acknowledge that they have each executed this Agreement voluntarily and of their own free will, after having the opportunity to obtain independent legal advice.


CounterPath    
Per:    
     
/s/ Steven Bruk    
Authorized Signatory    
     
     
SIGNED, SEALED AND DELIVERED by )  
Donovan Jones in the presence of: )  
  )  
/s/ Lauren Mainman ) /s/ Donovan Jones
Witness ) Donovan Jones
  )  

-4-



Exhibit 31.1

CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, David Karp, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of CounterPath Corporation;

   
2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

   
3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

   
4.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

     
  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

     
  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     
  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

     
  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


December 12, 2018 /s/ David Karp
  David Karp
  Interim Chief Executive Officer, Chief Financial Officer,
  Treasurer and Secretary
  (Principal Executive Officer, Principal Financial Officer
  and Principal Accounting Officer)



Exhibit 32.1

CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, David Karp, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that

1.

the quarterly report on Form 10-Q of CounterPath Corporation for the period ended October 31, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

   
2.

the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of CounterPath Corporation.


December 12, 2018 /s/ David Karp
  David Karp
  Interim Chief Executive Officer, Chief Financial Officer,
  Treasurer and Secretary
  (Principal Executive Officer, Principal Financial Officer
  and Principal Accounting Officer)